Rescue	O
by	O
cytokines	B-protein
of	O
apoptotic	O
cell	O
death	O
induced	O
by	O
IL-2	B-protein
deprivation	O
of	O
human	B-cell_line
antigen-specific	I-cell_line
T	I-cell_line
cell	I-cell_line
clones	I-cell_line
.	O

The	O
control	O
of	O
cell	O
survival	O
and	O
cell	O
death	O
is	O
of	O
central	O
importance	O
in	O
tissues	O
with	O
high	O
cell	O
turnover	O
such	O
as	O
the	O
lymphoid	O
system	O
.	O

We	O
have	O
examined	O
the	O
effect	O
of	O
cytokines	B-protein
on	O
IL-2	B-protein
deprivation-induced	O
apoptosis	O
of	O
human	B-cell_line
antigen-specific	I-cell_line
T	I-cell_line
helper	I-cell_line
clones	I-cell_line
with	O
different	O
cytokine	B-protein
production	O
profiles	O
.	O

We	O
found	O
that	O
IL-2	B-protein
,	O
interferon-alpha	B-protein
(	O
IFN-alpha	B-protein
)	O
,	O
and	O
IFN-beta	B-protein
inhibited	O
IL-2	B-protein
deprivation	O
apoptosis	O
in	O
Th0	B-cell_line
,	I-cell_line
Th1	I-cell_line
,	I-cell_line
and	I-cell_line
Th2	I-cell_line
clones	I-cell_line
.	O

We	O
also	O
found	O
that	O
IL-2	B-protein
protects	O
T	B-cell_line
cell	I-cell_line
clones	I-cell_line
from	O
IL-2	B-protein
deprivation	O
apoptosis	O
accompanying	O
active	O
proliferation	O
and	O
enhanced	O
expression	O
of	O
P53	B-protein
,	O
Rb	B-protein
and	O
Bcl-xL	B-protein
proteins	I-protein
.	O

In	O
contrast	O
,	O
IFN-alpha/beta	B-protein
rescued	O
T	B-cell_line
cell	I-cell_line
clones	I-cell_line
from	O
apoptosis	O
without	O
active	O
proliferation	O
,	O
and	O
expression	O
of	O
apoptosis-associated	B-protein
proteins	I-protein
tested	O
so	O
far	O
was	O
unaffected	O
.	O

This	O
may	O
be	O
due	O
to	O
the	O
fact	O
that	O
T	B-cell_type
cells	I-cell_type
treated	O
with	O
IL-2	B-protein
contained	O
those	O
located	O
in	O
S	O
+	O
G2/M	O
phases	O
of	O
the	O
cell	O
cycle	O
,	O
whereas	O
the	O
vast	O
majority	O
of	O
T	B-cell_type
cells	I-cell_type
treated	O
with	O
IFN-alpha/beta	B-protein
were	O
located	O
in	O
G0/G1	O
phase	O
.	O

IFN-alpha/beta	B-protein
specifically	O
induced	O
tyrosine	O
phosphorylation	O
and	O
translocation	O
into	O
nucleus	O
of	O
signal	B-protein
transducers	I-protein
and	I-protein
activators	I-protein
of	I-protein
transcription	I-protein
(	I-protein
STAT	I-protein
)	I-protein
2	I-protein
protein	I-protein
in	O
the	O
T	B-cell_line
cell	I-cell_line
clones	I-cell_line
.	O

In	O
addition	O
,	O
over-expression	O
of	O
STAT2	B-protein
by	O
transfection	O
of	O
the	O
cDNA	O
prevented	O
apoptosis	O
of	O
the	O
T	B-cell_line
cell	I-cell_line
clones	I-cell_line
.	O

Our	O
present	O
study	O
shows	O
that	O
IFN-alpha	B-protein
and	I-protein
-beta	I-protein
mediate	O
anti-apoptotic	O
effect	O
through	O
other	O
pathways	O
than	O
that	O
of	O
IL-2	B-protein
in	O
growth	O
factor	O
deprivation	O
apoptosis	O
.	O

Clin	NULL
Exp	NULL
Immunol	NULL
1997	NULL
;	NULL
109:185-193	NULL
Rescue	NULL
by	NULL
cytokines	NULL
of	NULL
apoptotic	NULL
cell	NULL
death	NULL
induced	NULL
by	NULL
IL-2	NULL
deprivation	NULL
of	NULL
human	NULL
antigen-specific	NULL
T	NULL
cell	NULL
clones	NULL
S.	NULL
KANEKO®*	NULL
#	NULL
,	NULL
N.	NULL
SUZUKI*	NULL
,	NULL
H.	NULL
KOIZUMIt	NULL
,	NULL
S.	NULL
YAMAMOTO	NULL
$	NULL
&	NULL
T.	NULL
SAKANE*	NULL
*Departments	NULL
of	NULL
Immunology	NULL
and	NULL
Medicine	NULL
and	NULL
{	NULL
Department	NULL
of	NULL
Pathology	NULL
,	NULL
St.	NULL
Marianna	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Kawasaki	NULL
,	NULL
Kanagawa	NULL
,	NULL
and	NULL
{	NULL
Department	NULL
of	NULL
Dermatology	NULL
,	NULL
Hiroshima	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Hiroshima	NULL
,	NULL
Japan	NULL
(	NULL
Accepted	NULL
for	NULL
publication	NULL
14	NULL
March	NULL
1997	NULL
)	NULL
SUMMARY	NULL
The	NULL
control	NULL
of	NULL
cell	NULL
survival	NULL
and	NULL
cell	NULL
death	NULL
is	NULL
of	NULL
central	NULL
importance	NULL
in	NULL
tissues	NULL
with	NULL
high	NULL
cell	NULL
turnover	NULL
such	NULL
as	NULL
the	NULL
lymphoid	NULL
system	NULL
.	NULL

We	NULL
have	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
cytokines	NULL
on	NULL
IL-2	NULL
deprivation-induced	NULL
apoptosis	NULL
of	NULL
human	NULL
antigen-specific	NULL
T	NULL
helper	NULL
clones	NULL
with	NULL
different	NULL
cytokine	NULL
production	NULL
profiles	NULL
.	NULL

We	NULL
found	NULL
that	NULL
IL-2	NULL
,	NULL
interferon-alpha	NULL
(	NULL
IFN-a	NULL
)	NULL
,	NULL
and	NULL
IFN-	NULL
$	NULL
inhibited	NULL
IL-2	NULL
deprivation	NULL
apoptosis	NULL
in	NULL
ThO	NULL
,	NULL
Th1	NULL
,	NULL
and	NULL
Th2	NULL
clones	NULL
.	NULL

We	NULL
also	NULL
found	NULL
that	NULL
IL-2	NULL
protects	NULL
T	NULL
cell	NULL
clones	NULL
from	NULL
IL-2	NULL
deprivation	NULL
apoptosis	NULL
accompanying	NULL
active	NULL
proliferation	NULL
and	NULL
enhanced	NULL
expression	NULL
of	NULL
P53	NULL
,	NULL
Rb	NULL
and	NULL
Bel-xL	NULL
proteins	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
IFN-	NULL
«	NULL
/8	NULL
rescued	NULL
T	NULL
cell	NULL
clones	NULL
from	NULL
apoptosis	NULL
without	NULL
active	NULL
proliferation	NULL
,	NULL
and	NULL
expression	NULL
of	NULL
apoptosis-associated	NULL
proteins	NULL
tested	NULL
so	NULL
far	NULL
was	NULL
unaffected	NULL
.	NULL

This	NULL
may	NULL
be	NULL
due	NULL
to	NULL
the	NULL
fact	NULL
that	NULL
T	NULL
cells	NULL
treated	NULL
with	NULL
IL-2	NULL
contained	NULL
those	NULL
located	NULL
in	NULL
S	NULL
+	NULL
G	NULL
;	NULL
/M	NULL
phases	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
,	NULL
whereas	NULL
the	NULL
vast	NULL
majority	NULL
of	NULL
T	NULL
cells	NULL
treated	NULL
with	NULL
IFN-	NULL
@	NULL
w/B	NULL
were	NULL
located	NULL
in	NULL
Gy/G	NULL
;	NULL
phase	NULL
.	NULL

specifically	NULL
induced	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
translocation	NULL
into	NULL
nucleus	NULL
of	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
(	NULL
STAT	NULL
)	NULL
2	NULL
protein	NULL
in	NULL
the	NULL
T	NULL
cell	NULL
clones	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
over-expression	NULL
of	NULL
STAT2	NULL
by	NULL
transfection	NULL
of	NULL
the	NULL
cDNA	NULL
prevented	NULL
apoptosis	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
clones	NULL
.	NULL

Our	NULL
present	NULL
study	NULL
shows	NULL
that	NULL
IFN-a	NULL
and	NULL
-8	NULL
mediate	NULL
anti-apoptotic	NULL
effect	NULL
through	NULL
other	NULL
pathways	NULL
than	NULL
that	NULL
of	NULL
IL-2	NULL
in	NULL
growth	NULL
factor	NULL
deprivation	NULL
apoptosis	NULL
.	NULL

Keywords	NULL
INTRODUCTION	NULL
Apoptosis	NULL
constitutes	NULL
a	NULL
systemic	NULL
means	NULL
of	NULL
cell	NULL
suicide	NULL
within	NULL
an	NULL
organism	NULL
during	NULL
normal	NULL
morphogenesis	NULL
,	NULL
tissue	NULL
remodelling	NULL
,	NULL
and	NULL
in	NULL
response	NULL
to	NULL
pathogenic	NULL
infections	NULL
or	NULL
other	NULL
irreparable	NULL
cell	NULL
damage	NULL
[	NULL
1-4	NULL
]	NULL
.	NULL

Several	NULL
biochemical	NULL
events	NULL
that	NULL
contribute	NULL
to	NULL
apoptosis	NULL
have	NULL
recently	NULL
been	NULL
elucidated	NULL
.	NULL

Genetic	NULL
evidence	NULL
in	NULL
nematodes	NULL
,	NULL
for	NULL
example	NULL
,	NULL
has	NULL
identified	NULL
both	NULL
positive	NULL
and	NULL
negative	NULL
regulators	NULL
of	NULL
apoptosis	NULL
[	NULL
5	NULL
]	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
the	NULL
key	NULL
pro-apoptotic	NULL
genes	NULL
are	NULL
mammalian	NULL
IL-1	NULL
{	NULL
§-converting	NULL
enzyme	NULL
(	NULL
ICE	NULL
)	NULL
and	NULL
apopain	NULL
,	NULL
members	NULL
of	NULL
a	NULL
new	NULL
family	NULL
of	NULL
cysteine	NULL
proteases	NULL
[	NULL
6,7	NULL
]	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
pro-apoptotic	NULL
effects	NULL
of	NULL
ICE	NULL
and	NULL
apopain	NULL
could	NULL
be	NULL
prevented	NULL
by	NULL
cell-death	NULL
suppressor	NULL
gene	NULL
,	NULL
the	NULL
proto-oncogene	NULL
,	NULL
product	NULL
Bel-2	NULL
.	NULL

The	NULL
fate	NULL
of	NULL
eukaryotic	NULL
cells	NULL
may	NULL
therefore	NULL
reside	NULL
in	NULL
the	NULL
balance	NULL
between	NULL
the	NULL
opposing	NULL
pro-apoptotic	NULL
effects	NULL
of	NULL
an	NULL
ICE/apopain-like	NULL
protease	NULL
[	NULL
6,7	NULL
]	NULL
and	NULL
an	NULL
upstream	NULL
regulatory	NULL
mechanism	NULL
involving	NULL
Bel-2	NULL
and/	NULL
or	NULL
its	NULL
homologues	NULL
[	NULL
8	NULL
,	NULL
9	NULL
]	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
Bel-2	NULL
,	NULL
its	NULL
homologues	NULL
,	NULL
such	NULL
as	NULL
Bcl-x	NULL
,	NULL
Bax	NULL
,	NULL
Bak	NULL
,	NULL
and	NULL
Bad	NULL
[	NULL
8,9	NULL
]	NULL
,	NULL
proto-oncogene	NULL
products	NULL
such	NULL
Correspondence	NULL
:	NULL
Dr	NULL
Sakae	NULL
Kaneko	NULL
,	NULL
Department	NULL
of	NULL
Dermatology	NULL
,	NULL
Hiroshima	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
1-2-3	NULL
Kaeumi	NULL
,	NULL
Minami-ku	NULL
,	NULL
Hiroshima	NULL
734	NULL
,	NULL
Japan	NULL
.	NULL

©	NULL
1997	NULL
Blackwell	NULL
Science	NULL
human	NULL
antigen-specific	NULL
T	NULL
cell	NULL
clone	NULL
apoptosis	NULL
STAT	NULL
as	NULL
c-Myc	NULL
and	NULL
anti-oncogenes	NULL
Rb	NULL
and	NULL
P53	NULL
,	NULL
also	NULL
exert	NULL
positive	NULL
and	NULL
negative	NULL
influences	NULL
on	NULL
the	NULL
apoptotic	NULL
cell	NULL
death	NULL
of	NULL
eukaryocytes	NULL
[	NULL
3,10	NULL
]	NULL
.	NULL

However	NULL
,	NULL
precise	NULL
roles	NULL
and	NULL
mechanisms	NULL
of	NULL
these	NULL
apoptosis-associated	NULL
gene	NULL
products	NULL
for	NULL
controlling	NULL
apoptotic	NULL
cell	NULL
death	NULL
remain	NULL
to	NULL
be	NULL
fully	NULL
understood	NULL
[	NULL
3,11	NULL
]	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
studies	NULL
that	NULL
address	NULL
whether	NULL
apoptotic	NULL
cell	NULL
death	NULL
of	NULL
human	NULL
mature	NULL
peripheral	NULL
T	NULL
lymphocytes	NULL
is	NULL
also	NULL
controlled	NULL
by	NULL
these	NULL
apoptosis-associated	NULL
gene	NULL
products	NULL
are	NULL
awaited	NULL
.	NULL

Peripheral	NULL
mature	NULL
T	NULL
lymphocytes	NULL
undergo	NULL
apoptotic	NULL
death	NULL
following	NULL
either	NULL
T	NULL
cell	NULL
receptor	NULL
stimulation	NULL
or	NULL
a	NULL
decrease	NULL
in	NULL
cytokine	NULL
production	NULL
after	NULL
antigen	NULL
clearance	NULL
,	NULL
in	NULL
order	NULL
to	NULL
remove	NULL
the	NULL
large	NULL
pool	NULL
of	NULL
antigen-specific	NULL
effecter	NULL
cells	NULL
that	NULL
could	NULL
potentially	NULL
contribute	NULL
to	NULL
excessive	NULL
inflammatory	NULL
reactions	NULL
or	NULL
autoimmune	NULL
responses	NULL
[	NULL
12	NULL
]	NULL
.	NULL

Indeed	NULL
,	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
dysfunction	NULL
of	NULL
apoptosis	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
can	NULL
lead	NULL
to	NULL
disease	NULL
[	NULL
4,13	NULL
]	NULL
.	NULL

T	NULL
cells	NULL
in	NULL
patients	NULL
with	NULL
AIDS	NULL
,	NULL
systemic	NULL
lupus	NULL
erythematosus	NULL
(	NULL
SLE	NULL
)	NULL
and	NULL
other	NULL
immunological	NULL
disorders	NULL
die	NULL
rapidly	NULL
by	NULL
apoptosis	NULL
.	NULL

Lymphocytopenia	NULL
,	NULL
especially	NULL
CD4*	NULL
T	NULL
cell	NULL
depletion	NULL
,	NULL
seen	NULL
in	NULL
patients	NULL
with	NULL
AIDS	NULL
correlates	NULL
well	NULL
with	NULL
their	NULL
prognosis	NULL
.	NULL

Thus	NULL
,	NULL
controlling	NULL
apoptotic	NULL
cell	NULL
death	NULL
would	NULL
be	NULL
a	NULL
desirable	NULL
means	NULL
of	NULL
treating	NULL
such	NULL
patients	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
examined	NULL
effects	NULL
of	NULL
various	NULL
cytokines	NULL
on	NULL
human	NULL
T	NULL
cell	NULL
apoptosis	NULL
using	NULL
house	NULL
dust	NULL
mite	NULL
(	NULL
HDM	NULL
)	NULL
-	NULL
and	NULL
purified	NULL
185	NULL
186	NULL
S.	NULL
Kaneko	NULL
et	NULL
al	NULL
.	NULL

protein	NULL
derivative	NULL
(	NULL
PPD	NULL
)	NULL
-specific	NULL
T	NULL
helper	NULL
clones	NULL
that	NULL
were	NULL
induced	NULL
to	NULL
undergo	NULL
apoptosis	NULL
by	NULL
IL-2	NULL
deprivation	NULL
.	NULL

We	NULL
found	NULL
that	NULL
apoptosis	NULL
in	NULL
antigen-specific	NULL
T	NULL
helper	NULL
(	NULL
Th	NULL
)	NULL
1	NULL
,	NULL
Th2	NULL
and	NULL
ThO	NULL
cell	NULL
clones	NULL
induced	NULL
by	NULL
IL-2	NULL
withdrawal	NULL
can	NULL
be	NULL
differently	NULL
regulated	NULL
by	NULL
distinct	NULL
cytokines	NULL
,	NULL
and	NULL
interferon-alpha/beta	NULL
(	NULL
IFN-w/68	NULL
)	NULL
have	NULL
potent	NULL
anti-apoptotic	NULL
effects	NULL
on	NULL
all	NULL
three	NULL
types	NULL
of	NULL
clone	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Reagents	NULL
HDM	NULL
(	NULL
Dermatophagoides	NULL
farinae	NULL
)	NULL
extract	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
Torii	NULL
Pharmaceutical	NULL
Co.	NULL
(	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

PPD	NULL
was	NULL
purchased	NULL
from	NULL
Japan	NULL
BCG	NULL
Co.	NULL
(	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

In	NULL
preliminary	NULL
experiments	NULL
,	NULL
we	NULL
determined	NULL
the	NULL
optimal	NULL
concentrations	NULL
of	NULL
HDM	NULL
(	NULL
10	NULL
ug/ml	NULL
!	NULL
)	NULL

and	NULL
PPD	NULL
(	NULL
1	NULL
pg/ml	NULL
!	NULL
)	NULL

in	NULL
the	NULL
proliferation	NULL
assays	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
following	NULL
human	NULL
cytokines	NULL
were	NULL
used	NULL
in	NULL
this	NULL
study	NULL
:	NULL
rIL-2	NULL
(	NULL
Shionogi	NULL
Pharmaceutical	NULL
Corp.	NULL
,	NULL
Osaka	NULL
,	NULL
Japan	NULL
)	NULL
,	NULL
IFN-	NULL
«	NULL
,	NULL
IFN-§	NULL
(	NULL
both	NULL
from	NULL
Mochida	NULL
Pharmaceutical	NULL
Corp.	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
,	NULL
and	NULL
IFN-y	NULL
(	NULL
Shionogi	NULL
Pharmaceutical	NULL
Corp.	NULL
)	NULL
.	NULL

Establishment	NULL
of	NULL
antigen-specific	NULL
T	NULL
cell	NULL
clones	NULL
and	NULL
their	NULL
cytokine	NULL
production	NULL
pattern	NULL
HDM-specific	NULL
and	NULL
PPD-specific	NULL
T	NULL
cell	NULL
clones	NULL
were	NULL
established	NULL
by	NULL
a	NULL
standard	NULL
procedure	NULL
using	NULL
limiting	NULL
dilution	NULL
technique	NULL
[	NULL
14,15	NULL
]	NULL
.	NULL

In	NULL
brief	NULL
,	NULL
HDM-specific	NULL
clones	NULL
were	NULL
generated	NULL
from	NULL
an	NULL
atopic	NULL
patient	NULL
who	NULL
was	NULL
allergic	NULL
to	NULL
HDM	NULL
,	NULL
and	NULL
PPD-specific	NULL
clones	NULL
were	NULL
generated	NULL
from	NULL
a	NULL
healthy	NULL
donor	NULL
who	NULL
was	NULL
positive	NULL
for	NULL
PPD	NULL
skin	NULL
reaction	NULL
.	NULL

Peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
(	NULL
PBMC	NULL
)	NULL
were	NULL
cultured	NULL
with	NULL
a	NULL
relevant	NULL
antigen	NULL
for	NULL
a	NULL
week	NULL
in	NULL
culture	NULL
media	NULL
consisting	NULL
of	NULL
RPMI1640	NULL
,	NULL
10	NULL
%	NULL
heat-inactivated	NULL
pooled	NULL
human	NULL
AB	NULL
serum	NULL
,	NULL
100	NULL
U/ml	NULL
penicillin	NULL
and	NULL
100	NULL
ug/ml	NULL
streptomycin	NULL
(	NULL
Life	NULL
Technolo-gies	NULL
,	NULL
Inc.	NULL
,	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

The	NULL
activated	NULL
T	NULL
cells	NULL
were	NULL
cloned	NULL
by	NULL
limiting	NULL
dilution	NULL
at	NULL
0-3	NULL
cell/well	NULL
and	NULL
cultured	NULL
with	NULL
5	NULL
%	NULL
10	NULL
``	NULL
irradiated	NULL
autologous	NULL
PBMC	NULL
as	NULL
feeder	NULL
cells	NULL
,	NULL
the	NULL
antigen	NULL
and	NULL
4	NULL
ng/ml	NULL
rIL-2	NULL
.	NULL

The	NULL
T	NULL
cell	NULL
clones	NULL
were	NULL
maintained	NULL
by	NULL
repetitive	NULL
stimulation	NULL
with	NULL
feeder	NULL
cells	NULL
and	NULL
antigen	NULL
once	NULL
a	NULL
week	NULL
and	NULL
2	NULL
ng/ml	NULL
of	NULL
rIL-2	NULL
twice	NULL
a	NULL
week	NULL
.	NULL

After	NULL
confirmation	NULL
of	NULL
antigen	NULL
specificity	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
clones	NULL
by	NULL
specific	NULL
proliferative	NULL
responses	NULL
to	NULL
HDM	NULL
and	NULL
PPD	NULL
,	NULL
they	NULL
were	NULL
used	NULL
as	NULL
antigen-specific	NULL
T	NULL
cell	NULL
clones	NULL
.	NULL

Cloned	NULL
T	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
cultured	NULL
for	NULL
7	NULL
days	NULL
with	NULL
the	NULL
antigen	NULL
and	NULL
feeder	NULL
cells	NULL
were	NULL
recovered	NULL
and	NULL
were	NULL
used	NULL
for	NULL
the	NULL
study	NULL
.	NULL

All	NULL
clones	NULL
used	NULL
in	NULL
the	NULL
present	NULL
study	NULL
expressed	NULL
TCR	NULL
«	NULL
$	NULL
,	NULL
CD3	NULL
,	NULL
CD4	NULL
,	NULL
CD45RO	NULL
,	NULL
but	NULL
were	NULL
negative	NULL
for	NULL
CD8	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

IL-4	NULL
and	NULL
IFN-y	NULL
levels	NULL
of	NULL
culture	NULL
supernatants	NULL
of	NULL
the	NULL
clones	NULL
stimulated	NULL
with	NULL
the	NULL
antigen	NULL
and	NULL
feeder	NULL
cells	NULL
for	NULL
16	NULL
h	NULL
were	NULL
measured	NULL
using	NULL
ELISA	NULL
kits	NULL
(	NULL
IL-4	NULL
:	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
,	NULL
Minneapolis	NULL
,	NULL
MN	NULL
;	NULL
IFN-y	NULL
:	NULL
BioSource	NULL
International	NULL
Inc.	NULL
,	NULL
Camarillo	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

We	NULL
assigned	NULL
ThO	NULL
,	NULL
Th1	NULL
and	NULL
Th2	NULL
as	NULL
follows	NULL
:	NULL
Th1	NULL
clones	NULL
that	NULL
produce	NULL
IFN-y	NULL
but	NULL
low	NULL
levels	NULL
of	NULL
IL-4	NULL
pg/ml	NULL
)	NULL
;	NULL
Th2	NULL
clones	NULL
that	NULL
produce	NULL
IL-4	NULL
but	NULL
undetectable	NULL
IFN-y	NULL
(	NULL
<	NULL
10pg/m	NULL
!	NULL
)	NULL

;	NULL
ThO	NULL
clones	NULL
that	NULL
produce	NULL
both	NULL
IL-4	NULL
and	NULL
IFN-y	NULL
(	NULL
see	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Proliferation	NULL
assay	NULL
In	NULL
order	NULL
to	NULL
characterize	NULL
proliferation	NULL
of	NULL
the	NULL
clones	NULL
,	NULL
5	NULL
x	NULL
10*	NULL
T	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
5	NULL
x	NULL
10	NULL
``	NULL
feeder	NULL
cells	NULL
and	NULL
optimal	NULL
concentrations	NULL
of	NULL
antigen	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
various	NULL
concentrations	NULL
of	NULL
cytokines	NULL
for	NULL
3	NULL
days	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
,	NULL
proliferation	NULL
for	NULL
24	NULL
h	NULL
of	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
various	NULL
cytokines	NULL
without	NULL
antigen	NULL
or	NULL
feeder	NULL
cells	NULL
was	NULL
measured	NULL
.	NULL

Proliferative	NULL
response	NULL
was	NULL
estimated	NULL
by	NULL
incorporation	NULL
of	NULL
°H-TIR	NULL
(	NULL
1	NULL
uCi/well	NULL
;	NULL
Amersham	NULL
International	NULL
,	NULL
Aylesbury	NULL
,	NULL
UK	NULL
)	NULL
during	NULL
the	NULL
last	NULL
16	NULL
h.	NULL
Data	NULL
shown	NULL
are	NULL
the	NULL
mean	NULL
ct/min	NULL
of	NULL
triplicate	NULL
cultures	NULL
,	NULL
and	NULL
s.e.m	NULL
.	NULL

of	NULL
the	NULL
triplicate	NULL
cultures	NULL
never	NULL
exceeded	NULL
15	NULL
%	NULL
of	NULL
the	NULL
mean	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Cell	NULL
viability	NULL
and	NULL
cell	NULL
morphology	NULL
Cell	NULL
viability	NULL
was	NULL
determined	NULL
by	NULL
light	NULL
microscopy	NULL
after	NULL
cell	NULL
staining	NULL
with	NULL
trypan	NULL
blue	NULL
[	NULL
16,17	NULL
]	NULL
.	NULL

For	NULL
ultrastructural	NULL
analysis	NULL
,	NULL
T	NULL
cells	NULL
were	NULL
fixed	NULL
with	NULL
1	NULL
%	NULL
glutaraldehyde	NULL
in	NULL
0-1	NULL
m	NULL
phosphate	NULL
buffer	NULL
,	NULL
post-fixed	NULL
with	NULL
1	NULL
%	NULL
osmium	NULL
tetroxide	NULL
,	NULL
and	NULL
embedded	NULL
in	NULL
Epon	NULL
according	NULL
to	NULL
routine	NULL
techniques	NULL
.	NULL

Thin	NULL
sections	NULL
were	NULL
mounted	NULL
on	NULL
nickel	NULL
grids	NULL
,	NULL
stained	NULL
with	NULL
uranyl	NULL
acetate	NULL
and	NULL
lead	NULL
citrate	NULL
,	NULL
and	NULL
examined	NULL
with	NULL
an	NULL
electron	NULL
microscope	NULL
[	NULL
18	NULL
]	NULL
.	NULL

DNA	NULL
staining	NULL
with	NULL
propidium	NULL
iodide	NULL
and	NULL
TUNEL	NULL
method	NULL
Cellular	NULL
DNA	NULL
was	NULL
stained	NULL
with	NULL
propidium	NULL
iodide	NULL
(	NULL
PID	NULL
)	NULL
,	NULL
and	NULL
analysed	NULL
by	NULL
a	NULL
flow	NULL
cytometer	NULL
[	NULL
19	NULL
]	NULL
.	NULL

Briefly	NULL
,	NULL
after	NULL
cell	NULL
culture	NULL
with	NULL
cytokines	NULL
,	NULL
T	NULL
cells	NULL
were	NULL
gently	NULL
resuspended	NULL
in	NULL
hypotonic	NULL
PI	NULL
solution	NULL
(	NULL
PI	NULL
50	NULL
pg/ml	NULL
!	NULL

in	NULL
0-1	NULL
%	NULL
sodium	NULL
citrate	NULL
plus	NULL
01	NULL
%	NULL
Triton	NULL
X-100	NULL
)	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
placed	NULL
at	NULL
4°C	NULL
in	NULL
the	NULL
dark	NULL
overnight	NULL
.	NULL

The	NULL
PI	NULL
fluorescence	NULL
of	NULL
isolated	NULL
nuclei	NULL
was	NULL
measured	NULL
with	NULL
a	NULL
FACScan	NULL
and	NULL
the	NULL
percentage	NULL
of	NULL
apoptotic	NULL
nuclei	NULL
(	NULL
subdiploid	NULL
DNA	NULL
peak	NULL
in	NULL
the	NULL
DNA	NULL
fluorescence	NULL
histogram	NULL
)	NULL
was	NULL
calculated	NULL
using	NULL
Consort	NULL
30	NULL
program	NULL
.	NULL

Percent	NULL
apoptotic	NULL
cell	NULL
death	NULL
=	NULL
(	NULL
subdiploid	NULL
DNA	NULL
(	NULL
A	NULL
region	NULL
)	NULL
subdiploid	NULL
DNA	NULL
(	NULL
A	NULL
region	NULL
)	NULL
+	NULL
diploid	NULL
DNA	NULL
(	NULL
B	NULL
region	NULL
)	NULL
)	NULL
x	NULL
100	NULL
%	NULL
.	NULL

We	NULL
found	NULL
that	NULL
the	NULL
variability	NULL
of	NULL
our	NULL
apoptosis	NULL
assay	NULL
using	NULL
PI	NULL
staining	NULL
(	NULL
s.e.m	NULL
.	NULL
)	NULL

never	NULL
exceeded	NULL
10	NULL
%	NULL
of	NULL
the	NULL
means	NULL
of	NULL
quadriplicate	NULL
estimation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
detect	NULL
DNA	NULL
strand	NULL
breaks	NULL
,	NULL
that	NULL
are	NULL
intimately	NULL
associated	NULL
with	NULL
an	NULL
apoptotic	NULL
response	NULL
,	NULL
an	NULL
in	NULL
sifu	NULL
cell	NULL
death	NULL
detection	NULL
kit	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
,	NULL
Mannheim	NULL
,	NULL
Germany	NULL
)	NULL
,	NULL
where	NULL
nicked	NULL
DNA	NULL
of	NULL
fixed	NULL
cells	NULL
was	NULL
labelled	NULL
by	NULL
the	NULL
incorporation	NULL
of	NULL
fluores-ceine-conjugated	NULL
dUTP	NULL
at	NULL
strand	NULL
breaks	NULL
by	NULL
terminal	NULL
deoxynucleotidyl	NULL
transferase	NULL
,	NULL
was	NULL
used	NULL
[	NULL
20	NULL
]	NULL
.	NULL

Immunoblotting	NULL
analysis	NULL
and	NULL
antibodies	NULL
To	NULL
study	NULL
expression	NULL
of	NULL
cytoplasmic	NULL
proteins	NULL
,	NULL
T	NULL
cell	NULL
clones	NULL
were	NULL
lysed	NULL
in	NULL
100	NULL
ul	NULL
Nonidet	NULL
P-40	NULL
lysis	NULL
buffer	NULL
[	NULL
21	NULL
]	NULL
containing	NULL
protease	NULL
inhibitors	NULL
(	NULL
1	NULL
mg/ml	NULL
PMSF	NULL
,	NULL
5	NULL
mm	NULL
EDTA	NULL
,	NULL
2	NULL
mg/m	NULL
!	NULL

aprotinin	NULL
,	NULL
and	NULL
2	NULL
mg/ml	NULL
leupeptin	NULL
)	NULL
.	NULL

In	NULL
the	NULL
experiments	NULL
where	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
was	NULL
studied	NULL
,	NULL
400	NULL
mm	NULL
NaVos	NULL
,	NULL
5	NULL
mm	NULL
EDTA	NULL
and	NULL
10	NULL
mm	NULL
NaF	NULL
were	NULL
included	NULL
in	NULL
the	NULL
buffer	NULL
.	NULL

To	NULL
study	NULL
translocation	NULL
of	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
(	NULL
STAT	NULL
)	NULL
proteins	NULL
,	NULL
nuclear	NULL
proteins	NULL
of	NULL
the	NULL
T	NULL
cells	NULL
were	NULL
recovered	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Dignam	NULL
et	NULL
a.	NULL
,	NULL
with	NULL
minor	NULL
modification	NULL
[	NULL
21,22	NULL
]	NULL
.	NULL

To	NULL
reduce	NULL
contamination	NULL
of	NULL
cytoplasmic	NULL
proteins	NULL
,	NULL
the	NULL
crude	NULL
nuclei	NULL
prepared	NULL
by	NULL
hypotonic	NULL
solution	NULL
were	NULL
washed	NULL
twice	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
resuspension	NULL
of	NULL
the	NULL
nuclei	NULL
in	NULL
high	NULL
salt	NULL
buffer	NULL
[	NULL
22	NULL
]	NULL
.	NULL

Samples	NULL
were	NULL
electrophoresed	NULL
on	NULL
a	NULL
4-20	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
under	NULL
reducing	NULL
condition	NULL
and	NULL
the	NULL
proteins	NULL
were	NULL
transferred	NULL
to	NULL
PVDF	NULL
membranes	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
first	NULL
antibody	NULL
and	NULL
biotin-labelled	NULL
goat	NULL
anti-mouse	NULL
IgG	NULL
or	NULL
anti-rabbit	NULL
IgG	NULL
antibody	NULL
,	NULL
followed	NULL
by	NULL
peroxidase-conjugated	NULL
streptavidin	NULL
.	NULL

Detection	NULL
was	NULL
carried	NULL
out	NULL
using	NULL
ECL	NULL
kit	NULL
(	NULL
Amersham	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

Antibodies	NULL
used	NULL
in	NULL
the	NULL
present	NULL
study	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
anti-Bel-2	NULL
(	NULL
Dako	NULL
,	NULL
Glostrup	NULL
,	NULL
Denmark	NULL
)	NULL
,	NULL
anti-Bcl-x	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
anti-Bax	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
,	NULL
anti-P53	NULL
(	NULL
Dako	NULL
)	NULL
,	NULL
anti-c-Myc	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
,	NULL
anti-Rb	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
,	NULL
anti-STAT1	NULL
,	NULL
anti-STAT2	NULL
,	NULL
and	NULL
anti-STAT3	NULL
(	NULL
the	NULL
latter	NULL
three	NULL
from	NULL
Transduction	NULL
Laboratories	NULL
,	NULL
Lexington	NULL
,	NULL
KT	NULL
)	NULL
.	NULL

Transfection	NULL
T	NULL
cell	NULL
clones	NULL
were	NULL
transfected	NULL
by	NULL
DEAE-dextran/chroloquine	NULL
©	NULL
1997	NULL
Blackwell	NULL
Scbence	NULL
Ltd	NULL
,	NULL
Clinical	NULL
and	NULL
Experimental	NULL
Immunology	NULL
,	NULL
109:185-193	NULL
Regulation	NULL
by	NULL
cytokines	NULL
of	NULL
human	NULL
T	NULL
cell	NULL
apoptosis	NULL
187	NULL
(	NULL
a	NULL
)	NULL
A	NULL
(	NULL
b	NULL
)	NULL
=~	NULL
x	NULL
100	NULL
Percent	NULL
FITC-Counts	NULL
A	NULL
A+B	NULL
;	NULL
Counts	NULL
positive	NULL
cells	NULL
e-	NULL
``	NULL
*~-~\.-BA	NULL
.	NULL

%	NULL
Apoptotic	NULL
500	NULL
cell	NULL
death	NULL
250	NULL
400	NULL
200	NULL
E	NULL
3	NULL
3	NULL
300	NULL
3	NULL
150	NULL
G	NULL
62.2	NULL
is	NULL
5111	NULL
=	NULL
200	NULL
=	NULL
100	NULL
100	NULL
50	NULL
Mu	NULL
0	NULL
P	NULL
«	NULL
0	NULL
se	NULL
500	NULL
250	NULL
400	NULL
200	NULL
Z	NULL
300	NULL
84	NULL
g	NULL
150	NULL
£4	NULL
200	NULL
100	NULL
100	NULL
L	NULL
50	NULL
0	NULL
#	NULL
m	NULL
m	NULL
500	NULL
253	NULL
400	NULL
200	NULL
&	NULL
0	NULL
&	NULL
soo	NULL
sas	NULL
-	NULL
$	NULL
09	NULL
90-3	NULL
&	NULL
200	NULL
&	NULL
100	NULL
100	NULL
J	NULL
,	NULL
50	NULL
0	NULL
ae	NULL
kulk	NULL
0	NULL
cag	NULL
oat	NULL
,	NULL
500	NULL
250	NULL
400	NULL
200	NULL
oo	NULL
.	NULL

oa	NULL
.	NULL

30	NULL
;	NULL
2	NULL
``	NULL
69	NULL
e	NULL
251	NULL
-	NULL
200	NULL
~	NULL
100	NULL
100	NULL
50	NULL
10°	NULL
10	NULL
'	NULL
10°	NULL
10°	NULL
10°	NULL
10	NULL
``	NULL
10°	NULL
10°	NULL
OR-FL	NULL
GR-FL	NULL
(	NULL
KMC253	NULL
)	NULL
was	NULL
cultured	NULL
for	NULL
24	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
either	NULL
IL-2	NULL
,	NULL
or	NULL
IFN-8	NULL
without	NULL
antigen	NULL
and	NULL
feeder	NULL
cells	NULL
to	NULL
induce	NULL
growth	NULL
factor	NULL
removal	NULL
apoptosis	NULL
.	NULL

Anti-FAS	NULL
antibody	NULL
was	NULL
included	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
.	NULL

The	NULL
extent	NULL
of	NULL
apoptotic	NULL
cell	NULL
death	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
clones	NULL
was	NULL
estimated	NULL
by	NULL
the	NULL
following	NULL
methods	NULL
.	NULL

(	NULL
a	NULL
)	NULL
DNA	NULL
staining	NULL
with	NULL
propidium	NULL
iodide	NULL
(	NULL
PD	NULL
)	NULL
.	NULL

(	NULL
b	NULL
)	NULL
The	NULL
TUNEL	NULL
method	NULL
.	NULL

(	NULL
c	NULL
)	NULL
Electron	NULL
microscopic	NULL
analysis	NULL
.	NULL

Concentrations	NULL
of	NULL
reagents	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
IL-2	NULL
,	NULL
10	NULL
ng/ml	NULL
;	NULL
anti-FAS	NULL
antibody	NULL
,	NULL
100	NULL
ng/ml	NULL
;	NULL
IFN-	NULL
$	NULL
,	NULL
10	NULL
000	NULL
U/ml	NULL
.	NULL

(	NULL
a	NULL
)	NULL
DNA	NULL
of	NULL
the	NULL
T	NULL
cells	NULL
was	NULL
stained	NULL
with	NULL
PI	NULL
and	NULL
analysed	NULL
by	NULL
a	NULL
flow	NULL
cytometer	NULL
.	NULL

The	NULL
PI	NULL
fluorescence	NULL
of	NULL
isolated	NULL
nuclei	NULL
was	NULL
measured	NULL
and	NULL
the	NULL
percentage	NULL
of	NULL
apoptotic	NULL
nuclei	NULL
(	NULL
subdiploid	NULL
DNA	NULL
peak	NULL
in	NULL
the	NULL
DNA	NULL
fluorescence	NULL
histogram	NULL
)	NULL
was	NULL
calculated	NULL
using	NULL
the	NULL
Consort	NULL
30	NULL
program	NULL
.	NULL

T	NULL
cells	NULL
in	NULL
S+	NULL
G	NULL
;	NULL
/M	NULL
phases	NULL
are	NULL
present	NULL
in	NULL
IL-2	NULL
but	NULL
not	NULL
in	NULL
IFN-A-treated	NULL
T	NULL
cell	NULL
clones	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Extent	NULL
of	NULL
apoptosis	NULL
was	NULL
estimated	NULL
by	NULL
detecting	NULL
DNA	NULL
strand	NULL
breaks	NULL
of	NULL
T	NULL
cells	NULL
,	NULL
that	NULL
are	NULL
intimately	NULL
associated	NULL
with	NULL
apoptotic	NULL
responses	NULL
.	NULL

Nicked	NULL
DNA	NULL
of	NULL
T	NULL
cells	NULL
was	NULL
labelled	NULL
with	NULL
FITC-conjugated	NULL
dUTP	NULL
by	NULL
terminal	NULL
deoxynucleotidyl	NULL
transferase	NULL
,	NULL
and	NULL
was	NULL
analysed	NULL
by	NULL
a	NULL
flow	NULL
cytometer	NULL
.	NULL

(	NULL
c	NULL
)	NULL
Electron	NULL
microscopic	NULL
examination	NULL
of	NULL
an	NULL
apoptotic	NULL
antigen-specific	NULL
T	NULL
cell	NULL
clone	NULL
(	NULL
KMC253	NULL
)	NULL
.	NULL

The	NULL
T	NULL
cell	NULL
clone	NULL
was	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
cytokines	NULL
.	NULL

IL-2-	NULL
and	NULL
IFN-B-treated	NULL
T	NULL
cell	NULL
clones	NULL
showed	NULL
characteristic	NULL
ultrastructural	NULL
features	NULL
of	NULL
live	NULL
cells	NULL
:	NULL
chromatin	NULL
is	NULL
organized	NULL
into	NULL
euchromain	NULL
(	NULL
light	NULL
)	NULL
and	NULL
heterochromatin	NULL
(	NULL
dense	NULL
)	NULL
,	NULL
and	NULL
the	NULL
cytoplasm	NULL
is	NULL
light	NULL
with	NULL
intact	NULL
organelles	NULL
.	NULL

Untreated	NULL
(	NULL
medium	NULL
)	NULL
T	NULL
cell	NULL
clones	NULL
exhibited	NULL
early	NULL
apoptotic	NULL
features	NULL
including	NULL
intense	NULL
chromatin	NULL
condensation	NULL
,	NULL
cytoplasmic	NULL
vacuolization	NULL
and	NULL
preserved	NULL
organelle	NULL
structure	NULL
.	NULL

©	NULL
1997	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
,	NULL
Clinical	NULL
and	NULL
Experimental	NULL
Immunology	NULL
,	NULL
109:185-193	NULL
188	NULL
S.	NULL
Kaneko	NULL
et	NULL
al	NULL
.	NULL

Table	NULL
1	NULL
.	NULL

Antigen-specific	NULL
T	NULL
cell	NULL
clones	NULL
used	NULL
in	NULL
the	NULL
present	NULL
study	NULL
+°H-TdR	NULL
incorporation	NULL
in	NULL
response	NULL
to	NULL
antigen	NULL
stimulation	NULL
with	NULL
or	NULL
without	NULL
cytokines	NULL
(	NULL
stimulation	NULL
index	NULL
)	NULL
*T	NULL
helper	NULL
_	NULL
*IL-4	NULL
*IFN-y	NULL
Designation	NULL
_	NULL
Antigen	NULL
type	NULL
(	NULL
pg/ml	NULL
)	NULL
(	NULL
pg/ml	NULL
)	NULL
Antigen	NULL
only	NULL
+	NULL
IL-2	NULL
_	NULL
+	NULL
IFN-	NULL
«	NULL
_	NULL
IFN-8	NULL
IFN-y	NULL
£Donor	NULL
KMC131	NULL
HDM	NULL
Th1	NULL
27-1	NULL
650	NULL
8201	NULL
+	NULL
110	NULL
ct/min	NULL
(	NULL
14	NULL
)	NULL
(	NULL
114	NULL
)	NULL
(	NULL
29	NULL
)	NULL
(	NULL
12	NULL
)	NULL
(	NULL
204	NULL
)	NULL
-	NULL
Asthma	NULL
KMC133	NULL
HDM	NULL
Th1	NULL
187	NULL
750	NULL
4459	NULL
+	NULL
165	NULL
ct/min	NULL
(	NULL
10	NULL
)	NULL
ND	NULL
ND	NULL
ND	NULL
ND	NULL
Asthma	NULL
KMC146	NULL
HDM	NULL
ThO	NULL
6704	NULL
2344	NULL
5820	NULL
+	NULL
562	NULL
ct/min	NULL
(	NULL
9:5	NULL
)	NULL
(	NULL
768	NULL
)	NULL
(	NULL
18	NULL
)	NULL
(	NULL
28	NULL
)	NULL
(	NULL
89	NULL
)	NULL
_	NULL
Asthma	NULL
KMC253	NULL
HDM	NULL
ThO	NULL
3810	NULL
739	NULL
21860	NULL
+	NULL
1157	NULL
ct/min	NULL
(	NULL
1093	NULL
)	NULL
_	NULL
(	NULL
3855	NULL
)	NULL
(	NULL
25	NULL
)	NULL
(	NULL
17	NULL
)	NULL
(	NULL
1002	NULL
)	NULL
Asthma	NULL
KMC248	NULL
HDM	NULL
Th2	NULL
1954	NULL
<	NULL
10	NULL
1622	NULL
+	NULL
234	NULL
ct/min	NULL
(	NULL
14	NULL
)	NULL
(	NULL
847	NULL
)	NULL
(	NULL
18	NULL
)	NULL
(	NULL
28	NULL
)	NULL
(	NULL
138	NULL
)	NULL
Asthma	NULL
KMC420	NULL
HDM	NULL
Th2	NULL
5862	NULL
<	NULL
10	NULL
1469	NULL
+	NULL
159	NULL
ct/min	NULL
(	NULL
7-5	NULL
)	NULL
(	NULL
101	NULL
)	NULL
(	NULL
12	NULL
)	NULL
(	NULL
14	NULL
)	NULL
(	NULL
2:0	NULL
)	NULL
Asthma	NULL
MIP20	NULL
PPD	NULL
Th1	NULL
<	NULL
10	NULL
432	NULL
14108	NULL
+	NULL
2203	NULL
ct/min	NULL
(	NULL
11	NULL
)	NULL
(	NULL
102	NULL
)	NULL
(	NULL
31	NULL
)	NULL
(	NULL
2:6	NULL
)	NULL
(	NULL
18:6	NULL
)	NULL
-	NULL
Normal	NULL
MIP30	NULL
PPD	NULL
Th1	NULL
<	NULL
10	NULL
6666	NULL
31098	NULL
+	NULL
2384	NULL
ct/min	NULL
(	NULL
11	NULL
)	NULL
ND	NULL
ND	NULL
ND	NULL
ND	NULL
Normal	NULL
*IL-4	NULL
and	NULL
IFN-y	NULL
production	NULL
were	NULL
measured	NULL
and	NULL
accordingly	NULL
T	NULL
helper	NULL
cell	NULL
types	NULL
were	NULL
assigned	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Specific	NULL
proliferation	NULL
of	NULL
T	NULL
cell	NULL
clones	NULL
in	NULL
response	NULL
to	NULL
relevant	NULL
antigen	NULL
was	NULL
measured	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Stimulation	NULL
index	NULL
was	NULL
calculated	NULL
as	NULL
follows	NULL
:	NULL
ct/min	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
antigen	NULL
with	NULL
or	NULL
without	NULL
cytokines/ct/min	NULL
in	NULL
the	NULL
culture	NULL
medium	NULL
.	NULL

We	NULL
verified	NULL
that	NULL
proliferation	NULL
of	NULL
T	NULL
cell	NULL
clones	NULL
without	NULL
antigen	NULL
stimulation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
various	NULL
cytokines	NULL
was	NULL
neglegible	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

$	NULL
Asthma	NULL
means	NULL
a	NULL
patient	NULL
with	NULL
bronchial	NULL
asthma	NULL
,	NULL
and	NULL
normal	NULL
a	NULL
normal	NULL
donor	NULL
with	NULL
positive	NULL
purified	NULL
protein	NULL
derivative	NULL
(	NULL
PPD	NULL
)	NULL
skin	NULL
reaction	NULL
.	NULL

ND	NULL
,	NULL
Not	NULL
done	NULL
.	NULL

Antigen-specific	NULL
T	NULL
cell	NULL
clones	NULL
were	NULL
cultured	NULL
for	NULL
3	NULL
days	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
irradiated	NULL
autologous	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
(	NULL
PBMC	NULL
)	NULL
,	NULL
antigen	NULL
and	NULL
various	NULL
cytokines	NULL
.	NULL

Proliferation	NULL
was	NULL
estimated	NULL
by	NULL
°H-TIR	NULL
incorporation	NULL
.	NULL

Concentrations	NULL
of	NULL
cytokines	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
IL-2	NULL
,	NULL
10	NULL
ng/ml	NULL
;	NULL
IFN-	NULL
,	NULL
10	NULL
000	NULL
U/ml	NULL
;	NULL
IFEN-	NULL
$	NULL
8	NULL
,	NULL
10	NULL
000	NULL
U/ml	NULL
;	NULL
IFN-y	NULL
,	NULL
1000	NULL
U/ml	NULL
.	NULL

Data	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
similar	NULL
experiments	NULL
.	NULL

method	NULL
with	NULL
empty	NULL
pME18S	NULL
expression	NULL
vector	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
Dr	NULL
K.	NULL
Maruyama	NULL
,	NULL
Tokyo	NULL
Medical	NULL
and	NULL
Dental	NULL
University	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
or	NULL
that	NULL
containing	NULL
a	NULL
full-length	NULL
STAT2	NULL
cDNA	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
Dr	NULL
J.	NULL
E.	NULL
Darnell	NULL
,	NULL
Jr.	NULL
,	NULL
The	NULL
Rockefeller	NULL
University	NULL
,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
)	NULL
[	NULL
23-25	NULL
]	NULL
.	NULL

The	NULL
transfected	NULL
T	NULL
cell	NULL
clones	NULL
were	NULL
maintained	NULL
in	NULL
culture	NULL
for	NULL
36	NULL
h.	NULL
Thereafter	NULL
,	NULL
these	NULL
clones	NULL
were	NULL
induced	NULL
to	NULL
die	NULL
by	NULL
growth	NULL
factor	NULL
deprivation	NULL
apoptosis	NULL
.	NULL

RESULTS	NULL
Characterization	NULL
of	NULL
antigen-specific	NULL
T	NULL
cell	NULL
clones	NULL
T	NULL
cell	NULL
clones	NULL
which	NULL
had	NULL
been	NULL
cultured	NULL
for	NULL
7	NULL
days	NULL
after	NULL
the	NULL
last	NULL
stimulation	NULL
with	NULL
feeder	NULL
cells	NULL
plus	NULL
the	NULL
antigen	NULL
were	NULL
recovered	NULL
for	NULL
use	NULL
in	NULL
apoptosis	NULL
assays	NULL
and	NULL
proliferation	NULL
assay	NULL
.	NULL

Thereafter	NULL
,	NULL
T	NULL
cell	NULL
clones	NULL
were	NULL
cultured	NULL
with	NULL
the	NULL
antigen	NULL
and	NULL
feeder	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
various	NULL
cytokines	NULL
for	NULL
3	NULL
days	NULL
to	NULL
characterize	NULL
cytokine-dependent	NULL
proliferation	NULL
of	NULL
antigen-specific	NULL
T	NULL
cell	NULL
clones	NULL
.	NULL

We	NULL
found	NULL
that	NULL
IL-2	NULL
induced	NULL
potent	NULL
proliferation	NULL
of	NULL
Th1	NULL
,	NULL
Th2	NULL
and	NULL
ThO	NULL
types	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
IFN-	NULL
and	NULL
rather	NULL
inhibited	NULL
antigen-specific	NULL
proliferation	NULL
of	NULL
the	NULL
clones	NULL
tested	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Induction	NULL
of	NULL
apoptotic	NULL
cell	NULL
death	NULL
of	NULL
antigen-specific	NULL
T	NULL
cell	NULL
clones	NULL
by	NULL
IL-2	NULL
deprivation	NULL
HDM-specific	NULL
and	NULL
PPD-specific	NULL
CD4*	NULL
T	NULL
cell	NULL
clones	NULL
were	NULL
harvested	NULL
after	NULL
7	NULL
days	NULL
culture	NULL
with	NULL
the	NULL
antigen	NULL
,	NULL
feeder	NULL
cells	NULL
and	NULL
IL-2	NULL
,	NULL
and	NULL
were	NULL
cultured	NULL
for	NULL
24	NULL
h	NULL
in	NULL
culture	NULL
media	NULL
alone	NULL
to	NULL
induce	NULL
IL-2	NULL
deprivation	NULL
apoptosis	NULL
.	NULL

The	NULL
extent	NULL
of	NULL
apoptotic	NULL
cell	NULL
death	NULL
was	NULL
estimated	NULL
by	NULL
the	NULL
following	NULL
methods	NULL
:	NULL
DNA	NULL
staining	NULL
with	NULL
PI	NULL
,	NULL
the	NULL
TUNEL	NULL
method	NULL
,	NULL
ladder	NULL
formation	NULL
by	NULL
DNA	NULL
electrophoresis	NULL
,	NULL
and	NULL
electron	NULL
microscopic	NULL
analysis	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1a	NULL
,	NULL
most	NULL
T	NULL
cells	NULL
cultured	NULL
with	NULL
10	NULL
ng/ml	NULL
of	NULL
rIL-2	NULL
were	NULL
viable	NULL
,	NULL
and	NULL
only	NULL
5-4	NULL
%	NULL
of	NULL
T	NULL
cells	NULL
were	NULL
found	NULL
dead	NULL
by	NULL
DNA	NULL
staining	NULL
method	NULL
with	NULL
PI	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
T	NULL
cells	NULL
cultured	NULL
with	NULL
culture	NULL
medium	NULL
rapidly	NULL
died	NULL
by	NULL
apoptosis	NULL
(	NULL
dead	NULL
cells	NULL
:	NULL
622	NULL
%	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
anti-FAS	NULL
antibody	NULL
,	NULL
induced	NULL
apoptosis	NULL
of	NULL
the	NULL
clones	NULL
(	NULL
dead	NULL
cells	NULL
:	NULL
925	NULL
%	NULL
)	NULL
.	NULL

This	NULL
finding	NULL
is	NULL
further	NULL
confirmed	NULL
by	NULL
ladder	NULL
formation	NULL
of	NULL
DNA	NULL
recovered	NULL
from	NULL
T	NULL
cells	NULL
cultured	NULL
for	NULL
24h	NULL
with	NULL
culture	NULL
media	NULL
,	NULL
a	NULL
sample	NULL
of	NULL
apoptotic	NULL
cell	NULL
death	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
results	NULL
of	NULL
cell	NULL
staining	NULL
with	NULL
a	NULL
TUNEL	NULL
method	NULL
(	NULL
Fig	NULL
.	NULL

1b	NULL
)	NULL
and	NULL
those	NULL
of	NULL
viable	NULL
cell	NULL
staining	NULL
with	NULL
trypan	NULL
blue	NULL
were	NULL
consistent	NULL
with	NULL
the	NULL
above	NULL
findings	NULL
.	NULL

After	NULL
24h	NULL
incubation	NULL
in	NULL
culture	NULL
medium	NULL
,	NULL
21	NULL
%	NULL
of	NULL
the	NULL
originally	NULL
seeded	NULL
antigen-specific	NULL
T	NULL
cell	NULL
clones	NULL
were	NULL
viable	NULL
,	NULL
and	NULL
addition	NULL
of	NULL
rIL-2	NULL
to	NULL
the	NULL
T	NULL
cell	NULL
clones	NULL
significantly	NULL
improved	NULL
recovery	NULL
of	NULL
viable	NULL
cells	NULL
(	NULL
viability	NULL
:	NULL
98	NULL
%	NULL
)	NULL
by	NULL
trypan	NULL
blue	NULL
staining	NULL
.	NULL

The	NULL
apoptotic	NULL
nature	NULL
of	NULL
IL-2	NULL
deprivation-induced	NULL
cell	NULL
death	NULL
of	NULL
T	NULL
cell	NULL
clones	NULL
was	NULL
further	NULL
confirmed	NULL
by	NULL
electron	NULL
microscopic	NULL
examination	NULL
;	NULL
T	NULL
cells	NULL
cultured	NULL
without	NULL
IL-2	NULL
(	NULL
medium	NULL
)	NULL
showed	NULL
typical	NULL
features	NULL
of	NULL
apoptotic	NULL
cells	NULL
:	NULL
reduced	NULL
cell	NULL
volume	NULL
,	NULL
condensed	NULL
Table	NULL
2	NULL
.	NULL

Effects	NULL
of	NULL
various	NULL
cytokines	NULL
on	NULL
growth	NULL
factor	NULL
deprivation-induced	NULL
apoptotic	NULL
cell	NULL
death	NULL
Percent	NULL
apoptotic	NULL
cell	NULL
death	NULL
Designation	NULL
_	NULL
Medium	NULL
only	NULL
+	NULL
IL-2	NULL
+	NULL
IFN-	NULL
+	NULL
-	NULL
+	NULL
IFN-y	NULL
KMC131	NULL
43	NULL
20	NULL
28	NULL
27	NULL
45	NULL
KMC133	NULL
70	NULL
11	NULL
46	NULL
47	NULL
73	NULL
KMC146	NULL
77	NULL
19	NULL
58	NULL
50	NULL
80	NULL
KMC253	NULL
62	NULL
54	NULL
30	NULL
283	NULL
60	NULL
KMC248	NULL
73	NULL
24	NULL
50	NULL
46	NULL
70	NULL
KMC420	NULL
77	NULL
30	NULL
47	NULL
43	NULL
71	NULL
MIP20	NULL
50	NULL
39	NULL
25	NULL
21	NULL
51	NULL
MIP30	NULL
57	NULL
26	NULL
39	NULL
38	NULL
55	NULL
T	NULL
cell	NULL
clones	NULL
were	NULL
cultured	NULL
for	NULL
24	NULL
h	NULL
to	NULL
induce	NULL
apoptosis	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
various	NULL
cytokines	NULL
.	NULL

Apoptotic	NULL
cell	NULL
death	NULL
was	NULL
measured	NULL
by	NULL
flow	NULL
cytometric	NULL
analysis	NULL
of	NULL
DNA	NULL
stained	NULL
with	NULL
propidium	NULL
iodide	NULL
(	NULL
PI	NULL
)	NULL
.	NULL

Cytokine	NULL
concentrations	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
IL-2	NULL
,	NULL
10	NULL
ng/ml	NULL
;	NULL
IFN-	NULL
«	NULL
,	NULL
10000	NULL
U/ml	NULL
;	NULL
IFN-8	NULL
,	NULL
10	NULL
.	NULL

000	NULL
U/ml	NULL
;	NULL
IFN-y	NULL
,	NULL
1000	NULL
U/ml	NULL
.	NULL

We	NULL
determined	NULL
the	NULL
optimal	NULL
concentration	NULL
of	NULL
IL-2	NULL
in	NULL
our	NULL
preliminary	NULL
experiments	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
at	NULL
least	NULL
three	NULL
experiments	NULL
for	NULL
each	NULL
Th	NULL
type	NULL
T	NULL
cell	NULL
clone	NULL
.	NULL

©	NULL
1997	NULL
Blackwell	NULL
Scbence	NULL
Ltd	NULL
,	NULL
Clinical	NULL
and	NULL
Experimental	NULL
Immunology	NULL
,	NULL
109:185-193	NULL
Regulation	NULL
by	NULL
cytokines	NULL
of	NULL
human	NULL
T	NULL
cell	NULL
apoptosis	NULL
189	NULL
Medium	NULL
IL-2	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL
)	NULL

Anti-FAS	NULL
Ab	NULL
(	NULL
10°	NULL
ng/m	NULL
!	NULL
)	NULL

IFN-	NULL
«	NULL
(	NULL
102	NULL
{	NULL
10°	NULL
U/m1	NULL
)	NULL
(	NULL
104	NULL
IFN-B	NULL
{	NULL
10°	NULL
U/m	NULL
!	NULL

1	NULL
)	NULL
(	NULL
10°	NULL
U/m	NULL
!	NULL

1	NULL
)	NULL
(	NULL
104	NULL
U/mI	NULL
)	NULL
IFN-y	NULL
(	NULL
10	NULL
U/m	NULL
!	NULL

I	NULL
)	NULL
(	NULL
10°	NULL
{	NULL
10°	NULL
U/m	NULL
!	NULL

I	NULL
)	NULL
|	NULL
0	NULL
20	NULL
40	NULL
60	NULL
80	NULL
100	NULL
Percent	NULL
apoptotic	NULL
cell	NULL
death	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

IFN-	NULL
@	NULL
/6	NULL
inhibit	NULL
cytokine	NULL
deprivation	NULL
apoptotic	NULL
cell	NULL
death	NULL
of	NULL
human	NULL
antigen-specific	NULL
T	NULL
cell	NULL
clones	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
.	NULL

A	NULL
T	NULL
cell	NULL
clone	NULL
(	NULL
KMC253	NULL
)	NULL
was	NULL
cultured	NULL
for	NULL
24	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
various	NULL
concentrations	NULL
of	NULL
cytokines	NULL
.	NULL

Apoptosis	NULL
of	NULL
the	NULL
clones	NULL
was	NULL
estimated	NULL
by	NULL
DNA	NULL
staining	NULL
with	NULL
propidium	NULL
iodide	NULL
(	NULL
PI	NULL
)	NULL
.	NULL

Results	NULL
presented	NULL
are	NULL
representative	NULL
of	NULL
four	NULL
independent	NULL
experiments	NULL
using	NULL
four	NULL
different	NULL
T	NULL
cell	NULL
clones	NULL
.	NULL

Essentially	NULL
the	NULL
same	NULL
results	NULL
were	NULL
obtained	NULL
when	NULL
the	NULL
T	NULL
cell	NULL
clone	NULL
was	NULL
cultured	NULL
for	NULL
48	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
cytokines	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

(	NULL
a	NULL
)	NULL
IL-2	NULL
IFN-B	NULL
(	NULL
b	NULL
)	NULL
IFN-B	NULL
IL-2	NULL
C-	NULL
I	NULL
1	NULL
0	NULL
6	NULL
12	NULL
24	NULL
6	NULL
12	NULL
-	NULL
24	NULL
(	NULL
h	NULL
)	NULL
0	NULL
6	NULL
12	NULL
24	NULL
6	NULL
12	NULL
24	NULL
(	NULL
h	NULL
)	NULL
Bcl-2	NULL
m	NULL
Bel-2	NULL
«	NULL
-o	NULL
amp	NULL
m	NULL
»	NULL
«	NULL
b	NULL
cs	NULL
cos	NULL
gam	NULL
B	NULL
aa	NULL
-	NULL
commas	NULL
o	NULL
ax	NULL
a-	NULL
C	NULL
--	NULL
~	NULL
.	NULL

pms	NULL
d.	NULL
B	NULL
~	NULL
«	NULL
*	NULL
mmm	NULL
«	NULL
4m	NULL
Fresh	NULL
Jurkat	NULL
cells	NULL
a*	NULL
s	NULL
t	NULL
Bcl.x	NULL
_	NULL
***	NULL
*	NULL
aot	NULL
UO	NULL
-o	NULL
88	NULL
i	NULL
--	NULL
Bcl-xL	NULL
B	NULL
f	NULL
cl-x	NULL
C	NULL
®	NULL
,	NULL
emume	NULL
--	NULL
-	NULL
Bcl-xL	NULL
--	NULL
Bcl-xS	NULL
pHs	NULL
rc	NULL
)	NULL
mm	NULL
mm	NULL
emmm	NULL
pss	NULL
aw	NULL
Kn	NULL
a.	NULL
igs	NULL
:	NULL
Tage	NULL
woe	NULL
-~	NULL
@	NULL
gm	NULL
RB	NULL
l	NULL
l	NULL
.	NULL

.	NULL

RB	NULL
em	NULL
-	NULL
weg	NULL
Woitge	NULL
gee	NULL
mome	NULL
F	NULL
RR	NULL
®	NULL
crosh	NULL
Jurkat	NULL
cells	NULL
wes	NULL
|	NULL
Fresh	NULL
Jurkat	NULL
cells	NULL
s	NULL
aum	NULL
.	NULL

--	NULL
c-Myc	NULL
c-Myc	NULL
aaum	NULL
--	NULL
c-Myc	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Analysis	NULL
of	NULL
apoptosis-associated	NULL
protein	NULL
expression	NULL
of	NULL
T	NULL
cells	NULL
rescued	NULL
from	NULL
apoptotic	NULL
cell	NULL
death	NULL
by	NULL
cytokines	NULL
.	NULL

T	NULL
helper	NULL
cell	NULL
clones	NULL
(	NULL
a	NULL
,	NULL
KMC146	NULL
;	NULL
b	NULL
,	NULL
KMC253	NULL
)	NULL
were	NULL
cultured	NULL
for	NULL
up	NULL
to	NULL
24	NULL
h	NULL
to	NULL
induce	NULL
apoptosis	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
either	NULL
IL-2	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL
)	NULL

or	NULL
IFN-	NULL
(	NULL
10	NULL
000	NULL
U/ml	NULL
)	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
recovered	NULL
at	NULL
the	NULL
time	NULL
indicated	NULL
and	NULL
expression	NULL
of	NULL
apoptosis-associated	NULL
proteins	NULL
was	NULL
examined	NULL
by	NULL
immunoblotting	NULL
analysis	NULL
.	NULL

As	NULL
a	NULL
positive	NULL
control	NULL
of	NULL
Bel-xS	NULL
and	NULL
c-Myc	NULL
,	NULL
Jurkat	NULL
cell	NULL
lysate	NULL
was	NULL
included	NULL
.	NULL

We	NULL
obtained	NULL
similar	NULL
results	NULL
in	NULL
at	NULL
least	NULL
three	NULL
independent	NULL
experiments	NULL
,	NULL
and	NULL
minor	NULL
alterations	NULL
of	NULL
protein	NULL
expression	NULL
in	NULL
IFN-A-treated	NULL
T	NULL
cells	NULL
were	NULL
not	NULL
reproducible	NULL
,	NULL
whereas	NULL
changes	NULL
in	NULL
IL-2-treated	NULL
T	NULL
cells	NULL
were	NULL
highly	NULL
reproducible	NULL
.	NULL

©	NULL
1997	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
,	NULL
Clinical	NULL
and	NULL
Experimental	NULL
Immunology	NULL
,	NULL
109:185-193	NULL
190	NULL
S.	NULL
Kaneko	NULL
et	NULL
al	NULL
.	NULL

nuclei	NULL
,	NULL
nuclear	NULL
fragmentation	NULL
,	NULL
loss	NULL
of	NULL
cell	NULL
surface	NULL
villi	NULL
and	NULL
preserved	NULL
organelle	NULL
structure	NULL
(	NULL
Fig	NULL
.	NULL

1¢c	NULL
)	NULL
.	NULL

Inhibition	NULL
of	NULL
IL-2	NULL
deprivation-induced	NULL
apoptotic	NULL
cell	NULL
death	NULL
by	NULL
cytokines	NULL
We	NULL
next	NULL
studied	NULL
whether	NULL
cytokines	NULL
prevent	NULL
apoptotic	NULL
cell	NULL
death	NULL
induced	NULL
by	NULL
IL-2	NULL
deprivation	NULL
of	NULL
human	NULL
antigen-specific	NULL
T	NULL
cell	NULL
clones	NULL
.	NULL

T	NULL
cell	NULL
clones	NULL
died	NULL
by	NULL
apoptosis	NULL
when	NULL
cultured	NULL
with	NULL
culture	NULL
medium	NULL
,	NULL
and	NULL
supplementation	NULL
of	NULL
IL-2	NULL
rescued	NULL
the	NULL
T	NULL
cell	NULL
clones	NULL
from	NULL
apoptotic	NULL
death	NULL
(	NULL
Fig	NULL
.	NULL

la	NULL
)	NULL
.	NULL

To	NULL
our	NULL
surprise	NULL
,	NULL
introduction	NULL
of	NULL
into	NULL
the	NULL
cell	NULL
culture	NULL
also	NULL
prevented	NULL
apoptotic	NULL
cell	NULL
death	NULL
induced	NULL
by	NULL
IL-2	NULL
deprivation	NULL
(	NULL
Fig	NULL
.	NULL

1a	NULL
)	NULL
.	NULL

The	NULL
inhibitory	NULL
effects	NULL
of	NULL
IFN-	NULL
@	NULL
/B	NULL
on	NULL
IL-2	NULL
deprivation	NULL
apoptosis	NULL
were	NULL
dose-dependent	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

As	NULL
a	NULL
next	NULL
step	NULL
,	NULL
we	NULL
tested	NULL
whether	NULL
the	NULL
cytokines	NULL
(	NULL
IL-2	NULL
,	NULL
IFN-	NULL
,	NULL
IFN-8	NULL
,	NULL
and	NULL
IFN-y	NULL
)	NULL
inhibited	NULL
apoptotic	NULL
cell	NULL
death	NULL
induced	NULL
by	NULL
IL-2	NULL
deprivation	NULL
of	NULL
other	NULL
HDM-specific	NULL
and	NULL
PPD-specific	NULL
T	NULL
cell	NULL
clones	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

The	NULL
T	NULL
cell	NULL
clones	NULL
were	NULL
recovered	NULL
,	NULL
and	NULL
cultured	NULL
for	NULL
24h	NULL
with	NULL
various	NULL
cytokines	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
feeder	NULL
cells	NULL
and	NULL
antigen	NULL
.	NULL

Significant	NULL
inhibition	NULL
(	NULL
>	NULL
20	NULL
%	NULL
)	NULL
of	NULL
IL-2	NULL
deprivation-induced	NULL
apoptosis	NULL
was	NULL
observed	NULL
in	NULL
all	NULL
clones	NULL
tested	NULL
,	NULL
including	NULL
ThO	NULL
,	NULL
Th1	NULL
and	NULL
Th2-type	NULL
T	NULL
helper	NULL
clones	NULL
when	NULL
IL-2	NULL
,	NULL
IFN-	NULL
@	NULL
,	NULL
and	NULL
IFN-§	NULL
were	NULL
introduced	NULL
into	NULL
the	NULL
cultures	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

Growth	NULL
stimulatory	NULL
activity	NULL
of	NULL
cytokines	NULL
that	NULL
inhibit	NULL
IL-2	NULL
deprivation-induced	NULL
apoptosis	NULL
It	NULL
is	NULL
important	NULL
to	NULL
know	NULL
whether	NULL
inhibition	NULL
of	NULL
IL-2	NULL
deprivation	NULL
apoptosis	NULL
accompanies	NULL
active	NULL
cell	NULL
proliferation	NULL
.	NULL

To	NULL
this	NULL
end	NULL
,	NULL
T	NULL
cell	NULL
clones	NULL
were	NULL
cultured	NULL
with	NULL
the	NULL
cytokine	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
the	NULL
feeder	NULL
cells	NULL
and	NULL
the	NULL
antigen	NULL
.	NULL

Thereafter	NULL
,	NULL
proliferation	NULL
induced	NULL
at	NULL
the	NULL
end	NULL
of	NULL
24-h	NULL
cell	NULL
culture	NULL
was	NULL
estimated	NULL
.	NULL

Potent	NULL
proliferation	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
clones	NULL
was	NULL
yielded	NULL
in	NULL
response	NULL
to	NULL
IL-2	NULL
(	NULL
proliferation	NULL
of	NULL
T	NULL
cells	NULL
with	NULL
IL-2	NULL
at	NULL
time	NULL
24	NULL
h	NULL
,	NULL
92.000	NULL
ct/min	NULL
)	NULL
.	NULL

It	NULL
is	NULL
intriguing	NULL
that	NULL
inhibited	NULL
IL-2	NULL
deprivation-induced	NULL
apoptosis	NULL
,	NULL
but	NULL
did	NULL
not	NULL
induce	NULL
active	NULL
proliferation	NULL
of	NULL
T	NULL
cell	NULL
clones	NULL
(	NULL
those	NULL
with	NULL
IFN-	NULL
at	NULL
time	NULL
24	NULL
h	NULL
,	NULL
5000	NULL
ct/min	NULL
,	NULL
and	NULL
those	NULL
without	NULL
cytokines	NULL
at	NULL
time	NULL
24	NULL
h	NULL
,	NULL
2000	NULL
ct/	NULL
min	NULL
)	NULL
.	NULL

This	NULL
finding	NULL
is	NULL
further	NULL
confirmed	NULL
by	NULL
DNA	NULL
staining	NULL
analysis	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1a	NULL
.	NULL

The	NULL
T	NULL
cells	NULL
treated	NULL
with	NULL
IL-2	NULL
contained	NULL
those	NULL
that	NULL
were	NULL
located	NULL
in	NULL
S+G/M	NULL
phases	NULL
of	NULL
cell	NULL
cycle	NULL
,	NULL
whereas	NULL
the	NULL
vast	NULL
majority	NULL
of	NULL
T	NULL
cells	NULL
treated	NULL
with	NULL
were	NULL
located	NULL
in	NULL
phase	NULL
.	NULL

Essentially	NULL
the	NULL
same	NULL
results	NULL
were	NULL
obtained	NULL
using	NULL
ThO	NULL
,	NULL
Th1	NULL
,	NULL
and	NULL
Th2	NULL
clones	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
suggest	NULL
that	NULL
anti-apoptotic	NULL
cytokines	NULL
may	NULL
be	NULL
classified	NULL
into	NULL
two	NULL
types	NULL
:	NULL
one	NULL
that	NULL
rescues	NULL
from	NULL
apoptosis	NULL
with	NULL
accompanying	NULL
active	NULL
proliferation	NULL
of	NULL
the	NULL
cells	NULL
,	NULL
the	NULL
other	NULL
that	NULL
protects	NULL
T	NULL
cells	NULL
from	NULL
apoptotic	NULL
cell	NULL
death	NULL
without	NULL
proliferation	NULL
.	NULL

Expression	NULL
of	NULL
apoptosis-associated	NULL
proteins	NULL
in	NULL
antigen-specific	NULL
T	NULL
cell	NULL
clones	NULL
rescued	NULL
by	NULL
cytokine	NULL
supplementation	NULL
The	NULL
precise	NULL
roles	NULL
and	NULL
mechanisms	NULL
of	NULL
apoptosis-associated	NULL
gene	NULL
products	NULL
,	NULL
such	NULL
as	NULL
Bel-2	NULL
,	NULL
Bax	NULL
,	NULL
Bel-x	NULL
,	NULL
P53	NULL
,	NULL
c-Myc	NULL
and	NULL
Rb	NULL
,	NULL
for	NULL
controlling	NULL
apoptotic	NULL
cell	NULL
death	NULL
remain	NULL
to	NULL
be	NULL
fully	NULL
understood	NULL
in	NULL
human	NULL
antigen-specific	NULL
T	NULL
cell	NULL
clones	NULL
[	NULL
3,11	NULL
]	NULL
.	NULL

Using	NULL
immunoblotting	NULL
analysis	NULL
,	NULL
we	NULL
examined	NULL
apoptosis-associated	NULL
proteins	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
clones	NULL
that	NULL
were	NULL
induced	NULL
to	NULL
die	NULL
by	NULL
IL-2	NULL
deprivation	NULL
apoptosis	NULL
.	NULL

T	NULL
cell	NULL
clones	NULL
were	NULL
cultured	NULL
in	NULL
culture	NULL
medium	NULL
for	NULL
24h	NULL
to	NULL
induce	NULL
apoptosis	NULL
.	NULL

Supplementation	NULL
of	NULL
IL-2	NULL
into	NULL
the	NULL
cell	NULL
cultures	NULL
rescued	NULL
the	NULL
T	NULL
cell	NULL
clones	NULL
from	NULL
apoptosis	NULL
.	NULL

Expression	NULL
of	NULL
P53	NULL
,	NULL
Rb	NULL
,	NULL
and	NULL
Bel-xL	NULL
proteins	NULL
was	NULL
significantly	NULL
up-regulated	NULL
during	NULL
culture	NULL
of	NULL
rescued	NULL
clones	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

However	NULL
,	NULL
expression	NULL
of	NULL
other	NULL
proteins	NULL
such	NULL
as	NULL
ThO	NULL
(	NULL
KMC253	NULL
)	NULL
{	NULL
a	NULL
)	NULL
IFN-B	NULL
0	NULL
1	NULL
25	NULL
0	NULL
5	NULL
15	NULL
30	NULL
_	NULL
60	NULL
(	NULL
min	NULL
)	NULL
kD	NULL
220	NULL
97	NULL
-	NULL
e	NULL
``	NULL
4	NULL
d	NULL
white	NULL
.	NULL

a-66	NULL
-	NULL
Moal	NULL
A	NULL
ee	NULL
``	NULL
ae	NULL
=s	NULL
46	NULL
30	NULL
14	NULL
-	NULL
agen	NULL
.	NULL

co	NULL
ThO	NULL
(	NULL
KMC253	NULL
)	NULL
(	NULL
b	NULL
)	NULL
IL-2	NULL
0	NULL
1	NULL
2-5	NULL
5	NULL
15	NULL
30	NULL
-	NULL
60	NULL
(	NULL
min	NULL
)	NULL
kD	NULL
220	NULL
97	NULL
¢	NULL
w	NULL
m	NULL
-	NULL
&	NULL
wom-h	NULL
«	NULL
-am	NULL
gop	NULL
%	NULL
4	NULL
66	NULL
-	NULL
P	NULL
®	NULL
t	NULL
mm	NULL
t	NULL
46	NULL
toe	NULL
4	NULL
os	NULL
@	NULL
t	NULL
64	NULL
Tt	NULL
HL	NULL
30	NULL
14	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Analysis	NULL
of	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
cytoplasm	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
clone	NULL
rescued	NULL
by	NULL
IL-2	NULL
and	NULL
IFN-8	NULL
.	NULL

Cytoplasmic	NULL
proteins	NULL
were	NULL
recovered	NULL
from	NULL
the	NULL
T	NULL
cell	NULL
clones	NULL
rescued	NULL
from	NULL
apoptosis	NULL
by	NULL
IFN-	NULL
$	NULL
or	NULL
IL-2	NULL
.	NULL

Immunoblotting	NULL
was	NULL
carried	NULL
out	NULL
using	NULL
anti-phosphotyrosine	NULL
MoAb	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
at	NULL
least	NULL
three	NULL
experiments	NULL
.	NULL

An	NULL
open	NULL
triangle	NULL
indicates	NULL
85-kD	NULL
protein	NULL
,	NULL
a	NULL
closed	NULL
triangle	NULL
91-kD	NULL
protein	NULL
,	NULL
and	NULL
two	NULL
closed	NULL
triangles	NULL
110-kD	NULL
protein	NULL
.	NULL

Bel-2	NULL
and	NULL
Bax	NULL
was	NULL
unchanged	NULL
during	NULL
the	NULL
24	NULL
h	NULL
culture	NULL
period	NULL
.	NULL

To	NULL
our	NULL
surprise	NULL
,	NULL
none	NULL
of	NULL
the	NULL
apoptosis-associated	NULL
proteins	NULL
examined	NULL
in	NULL
this	NULL
study	NULL
were	NULL
affected	NULL
significantly	NULL
during	NULL
rescue	NULL
by	NULL
treatment	NULL
.	NULL

This	NULL
finding	NULL
may	NULL
be	NULL
associated	NULL
with	NULL
the	NULL
fact	NULL
that	NULL
IFN-treated	NULL
T	NULL
cells	NULL
locate	NULL
in	NULL
the	NULL
Go/G	NULL
;	NULL
phase	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

It	NULL
is	NULL
intriguing	NULL
that	NULL
c-Myc	NULL
and	NULL
Bel-xS	NULL
proteins	NULL
were	NULL
never	NULL
detected	NULL
in	NULL
CD4*	NULL
T	NULL
cell	NULL
clones	NULL
we	NULL
have	NULL
tested	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Nonetheless	NULL
,	NULL
a	NULL
T	NULL
cell	NULL
line	NULL
,	NULL
Jurkat	NULL
,	NULL
expressed	NULL
abundant	NULL
c-Myc	NULL
and	NULL
Bcel-xS	NULL
proteins	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
IL-2	NULL
protects	NULL
T	NULL
cell	NULL
clones	NULL
from	NULL
IL-2	NULL
deprivation-induced	NULL
apoptosis	NULL
using	NULL
a	NULL
pathway	NULL
in	NULL
which	NULL
P53	NULL
,	NULL
Rb	NULL
and	NULL
Bel-xL	NULL
protein	NULL
expression	NULL
is	NULL
up-regulated	NULL
.	NULL

This	NULL
pathway	NULL
©	NULL
1997	NULL
Blackwell	NULL
Scbence	NULL
Ltd	NULL
,	NULL
Clinical	NULL
and	NULL
Experimental	NULL
Immunology	NULL
,	NULL
109:185-193	NULL
Regulation	NULL
by	NULL
cytokines	NULL
of	NULL
human	NULL
T	NULL
cell	NULL
apoptosis	NULL
191	NULL
(	NULL
a	NULL
)	NULL
ThO	NULL
(	NULL
KMC253	NULL
)	NULL
o	NULL
Cytosolic	NULL
protein	NULL
Nuclear	NULL
protein	NULL
Téséitrlgﬁ	NULL
w	NULL
a	NULL
//	NULL
i	NULL
0	NULL
25	NULL
150	NULL
60	NULL
0	NULL
25	NULL
15	NULL
60	NULL
(	NULL
min	NULL
}	NULL
/	NULL
was	NULL
cum	NULL
»	NULL
qu	NULL
»	NULL
cum	NULL
worse	NULL
.	NULL

atic	NULL
(	NULL
b	NULL
)	NULL
Postitive	NULL
Nuclear	NULL
protein	NULL
_	NULL
IL-2	NULL
IFN-B	NULL
IFN-y	NULL
control	NULL
10	NULL
of	NULL
I	NULL
1	NULL
0	NULL
1003	NULL
6	NULL
10	NULL
3	NULL
6	NULL
1003	NULL
6	NULL
(	NULL
h	NULL
)	NULL
/	NULL
STAT-1	NULL
beige	NULL
£	NULL
wom	NULL
.	NULL

-	NULL
<	NULL
STAT-2	NULL
,	NULL
*	NULL
wor	NULL
«	NULL
a-STAT-3	NULL
wee	NULL
.	NULL

>	NULL
With	NULL
«	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Analysis	NULL
of	NULL
STAT	NULL
proteins	NULL
in	NULL
the	NULL
T	NULL
cell	NULL
clones	NULL
rescued	NULL
from	NULL
apoptosis	NULL
by	NULL
IL-2	NULL
and	NULL
IFN-§	NULL
.	NULL

T	NULL
cell	NULL
clones	NULL
were	NULL
cultured	NULL
to	NULL
induce	NULL
apoptosis	NULL
in	NULL
culture	NULL
medium	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IFN-8	NULL
(	NULL
10	NULL
000	NULL
IFN-y	NULL
(	NULL
1000	NULL
U/ml	NULL
)	NULL
or	NULL
IL-2	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
.	NULL

After	NULL
cell	NULL
culture	NULL
,	NULL
cytoplasmic	NULL
proteins	NULL
and	NULL
nuclear	NULL
proteins	NULL
of	NULL
the	NULL
T	NULL
cells	NULL
were	NULL
separately	NULL
recovered	NULL
.	NULL

Translocation	NULL
of	NULL
STAT2	NULL
in	NULL
human	NULL
T	NULL
cell	NULL
clones	NULL
was	NULL
evident	NULL
in	NULL
the	NULL
T	NULL
cell	NULL
clone	NULL
treated	NULL
with	NULL
IFN-8	NULL
.	NULL

accompanies	NULL
active	NULL
cell	NULL
proliferation	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
IFN-	NULL
@	NULL
/f	NULL
rescues	NULL
T	NULL
cell	NULL
clones	NULL
from	NULL
IL-2	NULL
deprivation-induced	NULL
apoptosis	NULL
without	NULL
accompanying	NULL
active	NULL
cell	NULL
proliferation	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
mediate	NULL
anti-apoptotic	NULL
effect	NULL
through	NULL
a	NULL
pathway	NULL
distinct	NULL
from	NULL
that	NULL
of	NULL
IL-2	NULL
.	NULL

IFN-BG-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
cytoplasmic	NULL
proteins	NULL
In	NULL
order	NULL
to	NULL
elucidate	NULL
the	NULL
IFN-	NULL
@	NULL
/6-mediated	NULL
signalling	NULL
pathway	NULL
that	NULL
prevents	NULL
IL-2	NULL
deprivation-induced	NULL
apoptosis	NULL
of	NULL
human	NULL
T	NULL
cell	NULL
Untransfected	NULL
KMC253	NULL
Untransfected	NULL
KMC253	NULL
+	NULL
IFN-B	NULL
Empty	NULL
pME18S	NULL
transfected	NULL
KMC253	NULL
+	NULL
IFN-B	NULL
Empty	NULL
pME18S	NULL
transfected	NULL
KMC253	NULL
pME18S-STAT2	NULL
cDNA	NULL
transfected	NULL
KMC253	NULL
25	NULL
30	NULL
clones	NULL
,	NULL
we	NULL
examined	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
the	NULL
cytoplasmic	NULL
proteins	NULL
of	NULL
IFN-	NULL
@	NULL
/	NULL
$	NULL
B-treated	NULL
T	NULL
cell	NULL
clones	NULL
.	NULL

The	NULL
T	NULL
cell	NULL
clones	NULL
were	NULL
cultured	NULL
to	NULL
induce	NULL
IL-2-deprivation	NULL
apoptosis	NULL
with	NULL
or	NULL
without	NULL
IFN-	NULL
«	NULL
/f	NULL
,	NULL
and	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
the	NULL
T	NULL
cells	NULL
was	NULL
examined	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
IFN-8	NULL
stimulation	NULL
and	NULL
IL-2	NULL
stimulation	NULL
induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
several	NULL
proteins	NULL
in	NULL
HDM-specific	NULL
human	NULL
T	NULL
cell	NULL
clones	NULL
.	NULL

Of	NULL
note	NULL
is	NULL
the	NULL
fact	NULL
that	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
91-kD	NULL
protein	NULL
was	NULL
evident	NULL
in	NULL
both	NULL
and	NULL
IL-2-stimulated	NULL
T	NULL
cells	NULL
with	NULL
a	NULL
similar	NULL
kinetics	NULL
(	NULL
1-30	NULL
min	NULL
)	NULL
.	NULL

However	NULL
,	NULL
a	NULL
110-kD	NULL
protein	NULL
was	NULL
specifically	NULL
tyrosine	NULL
phosphorylated	NULL
in	NULL
the	NULL
T	NULL
cells	NULL
,	NULL
at	NULL
time	NULL
15-60	NULL
min	NULL
.	NULL

IL-2-treated	NULL
T	NULL
cells	NULL
contained	NULL
a	NULL
tyrosine	NULL
phosphorylated	NULL
85-kD	NULL
protein	NULL
specifically	NULL
at	NULL
time	NULL
1-30	NULL
min	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
IFN-w/6	NULL
pathway	NULL
utilizes	NULL
STAT1a	NULL
(	NULL
91	NULL
kD	NULL
)	NULL
,	NULL
STAT1Ib	NULL
(	NULL
84	NULL
kD	NULL
)	NULL
and	NULL
STAT2	NULL
(	NULL
110	NULL
kD	NULL
)	NULL
to	NULL
transduce	NULL
the	NULL
relevant	NULL
signal	NULL
to	NULL
the	NULL
nucleus	NULL
[	NULL
24-26	NULL
]	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
91-	NULL
and	NULL
110-kD	NULL
proteins	NULL
that	NULL
were	NULL
tyrosine	NULL
phosphorylated	NULL
in	NULL
the	NULL
T	NULL
cells	NULL
rescued	NULL
from	NULL
apoptosis	NULL
by	NULL
IFN-	NULL
«	NULL
/f	NULL
treatment	NULL
were	NULL
likely	NULL
to	NULL
be	NULL
STAT1a	NULL
and	NULL
STAT2	NULL
,	NULL
respectively	NULL
.	NULL

Stimulation	NULL
by	NULL
IL-2	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
clones	NULL
induced	NULL
the	NULL
85-	NULL
and	NULL
91-kD	NULL
proteins	NULL
.	NULL

It	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
IL-2	NULL
signalling	NULL
utilizes	NULL
STAT3	NULL
(	NULL
89	NULL
kD	NULL
,	NULL
minor	NULL
form	NULL
84	NULL
kD	NULL
)	NULL
and	NULL
STATS	NULL
(	NULL
92	NULL
kD	NULL
)	NULL
[	NULL
24,27,28	NULL
]	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
85-	NULL
and	NULL
91-kD	NULL
proteins	NULL
that	NULL
were	NULL
tyrosine	NULL
phosphorylated	NULL
in	NULL
the	NULL
IL-2-treated	NULL
T	NULL
cell	NULL
clones	NULL
represent	NULL
STAT3	NULL
and	NULL
STATS5	NULL
,	NULL
respectively	NULL
.	NULL

IFN-B	NULL
,	NULL
but	NULL
not	NULL
IL-2	NULL
nor	NULL
IFN-y	NULL
,	NULL
induces	NULL
translocation	NULL
from	NULL
cytoplasm	NULL
to	NULL
nucleus	NULL
of	NULL
STAT	NULL
It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
Janus	NULL
kinases/Just	NULL
another	NULL
kinases	NULL
(	NULL
JAKs	NULL
)	NULL
and	NULL
STATs	NULL
in	NULL
the	NULL
cytoplasm	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
signal	NULL
transduction	NULL
pathway	NULL
of	NULL
IFN-	NULL
@	NULL
/8	NULL
[	NULL
24	NULL
]	NULL
,	NULL
and	NULL
STAT2	NULL
protein	NULL
is	NULL
translocated	NULL
from	NULL
cytoplasm	NULL
to	NULL
nucleus	NULL
after	NULL
treatment	NULL
of	NULL
cells	NULL
with	NULL
IFN-	NULL
@	NULL
/8	NULL
[	NULL
26,29	NULL
]	NULL
.	NULL

As	NULL
a	NULL
next	NULL
step	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
STAT2	NULL
protein	NULL
translocates	NULL
from	NULL
cytoplasm	NULL
into	NULL
nucleus	NULL
of	NULL
antigen-specific	NULL
human	NULL
T	NULL
cell	NULL
clones	NULL
rescued	NULL
with	NULL
IFN-	NULL
@	NULL
/	NULL
$	NULL
treatment	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
we	NULL
detected	NULL
accumulation	NULL
of	NULL
STAT2	NULL
protein	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
human	NULL
T	NULL
cell	NULL
clones	NULL
after	NULL
treatment	NULL
for	NULL
1	NULL
h	NULL
with	NULL
IFN-6	NULL
.	NULL

This	NULL
accumulation	NULL
of	NULL
STAT2	NULL
protein	NULL
in	NULL
the	NULL
nuclei	NULL
was	NULL
specific	NULL
for	NULL
IFN-	NULL
,	NULL
because	NULL
such	NULL
i	NULL
n	NULL
m	NULL
1	NULL
|	NULL
|	NULL
|	NULL
|	NULL
|	NULL
35	NULL
40	NULL
45	NULL
50	NULL
55	NULL
60	NULL
65	NULL
70	NULL
75	NULL
Percent	NULL
apoptosis	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

Effects	NULL
of	NULL
STAT2	NULL
cDNA	NULL
transfection	NULL
on	NULL
the	NULL
apoptosis	NULL
of	NULL
T	NULL
cell	NULL
clones	NULL
.	NULL

T	NULL
cell	NULL
clones	NULL
were	NULL
transfected	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
,	NULL
and	NULL
induced	NULL
to	NULL
die	NULL
via	NULL
growth	NULL
factor	NULL
deprivation	NULL
apoptosis	NULL
.	NULL

Apoptotic	NULL
cell	NULL
death	NULL
was	NULL
measured	NULL
by	NULL
flow	NULL
cytometric	NULL
analysis	NULL
of	NULL
DNA	NULL
stained	NULL
with	NULL
propidium	NULL
iodide	NULL
(	NULL
PI	NULL
)	NULL
.	NULL

The	NULL
result	NULL
shown	NULL
is	NULL
a	NULL
representative	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
using	NULL
KMC253	NULL
T	NULL
cell	NULL
clone	NULL
,	NULL
and	NULL
essentially	NULL
the	NULL
same	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
two	NULL
independent	NULL
experiments	NULL
with	NULL
KMC146	NULL
T	NULL
cell	NULL
clone	NULL
.	NULL

©	NULL
1997	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
,	NULL
Clinical	NULL
and	NULL
Experimental	NULL
Immunology	NULL
,	NULL
109:185-193	NULL
192	NULL
S.	NULL
Kaneko	NULL
et	NULL
al	NULL
.	NULL

accumulation	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
the	NULL
nuclear	NULL
proteins	NULL
of	NULL
T	NULL
cell	NULL
clones	NULL
treated	NULL
with	NULL
IFN-y	NULL
or	NULL
IL-2	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
anti-apoptotic	NULL
effect	NULL
by	NULL
IFN-8	NULL
in	NULL
antigen-specific	NULL
T	NULL
cell	NULL
clones	NULL
may	NULL
be	NULL
mediated	NULL
through	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT2	NULL
in	NULL
the	NULL
cytoplasm	NULL
and	NULL
translocation	NULL
into	NULL
nucleus	NULL
.	NULL

To	NULL
confirm	NULL
the	NULL
involvement	NULL
of	NULL
STAT2	NULL
protein	NULL
in	NULL
the	NULL
anti-apoptotic	NULL
activity	NULL
of	NULL
IFN-w/B	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
STAT2	NULL
overexpression	NULL
by	NULL
DNA	NULL
transfection	NULL
confers	NULL
resistance	NULL
to	NULL
growth	NULL
factor	NULL
deprivation	NULL
apoptosis	NULL
.	NULL

T	NULL
cell	NULL
clones	NULL
were	NULL
transfected	NULL
with	NULL
empty	NULL
pME18S	NULL
vector	NULL
or	NULL
vector	NULL
containing	NULL
STAT2	NULL
cDNA	NULL
.	NULL

The	NULL
levels	NULL
of	NULL
STAT2	NULL
protein	NULL
expression	NULL
were	NULL
analysed	NULL
by	NULL
Western	NULL
blotting	NULL
analysis	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
;	NULL
transfectants	NULL
with	NULL
empty	NULL
vector	NULL
did	NULL
not	NULL
have	NULL
detectable	NULL
level	NULL
of	NULL
STAT2	NULL
protein	NULL
in	NULL
the	NULL
cytoplasm	NULL
,	NULL
whereas	NULL
transfectants	NULL
with	NULL
pME18S	NULL
containing	NULL
STAT2	NULL
cDNA	NULL
expressed	NULL
high	NULL
levels	NULL
of	NULL
STAT2	NULL
protein	NULL
by	NULL
Western	NULL
blotting	NULL
analysis	NULL
.	NULL

The	NULL
transfectants	NULL
were	NULL
cultured	NULL
for	NULL
36h	NULL
to	NULL
induce	NULL
STAT2	NULL
protein	NULL
overexpression	NULL
.	NULL

Thereafter	NULL
,	NULL
T	NULL
cell	NULL
clones	NULL
were	NULL
recovered	NULL
,	NULL
counted	NULL
and	NULL
were	NULL
recultured	NULL
to	NULL
induce	NULL
growth	NULL
factor	NULL
deprivation	NULL
apoptosis	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
T	NULL
cell	NULL
clones	NULL
transfected	NULL
with	NULL
STAT2	NULL
expression	NULL
vector	NULL
were	NULL
rather	NULL
refractory	NULL
to	NULL
growth	NULL
factor	NULL
deprivation	NULL
apoptosis	NULL
.	NULL

These	NULL
data	NULL
strongly	NULL
suggest	NULL
that	NULL
a	NULL
signalling	NULL
pathway	NULL
involving	NULL
STAT2	NULL
protein	NULL
is	NULL
causally	NULL
associated	NULL
with	NULL
prevention	NULL
of	NULL
apoptosis	NULL
in	NULL
human	NULL
T	NULL
cell	NULL
clones	NULL
.	NULL

DISCUSSION	NULL
Growth	NULL
factor	NULL
withdrawal-induced	NULL
apoptosis	NULL
in	NULL
vitro	NULL
may	NULL
represent	NULL
a	NULL
situation	NULL
in	NULL
vivo	NULL
in	NULL
which	NULL
cytokine	NULL
production	NULL
is	NULL
diminished	NULL
after	NULL
antigen	NULL
clearance	NULL
,	NULL
leading	NULL
to	NULL
the	NULL
removal	NULL
of	NULL
a	NULL
large	NULL
,	NULL
potentially	NULL
harmful	NULL
,	NULL
pool	NULL
of	NULL
antigen-specific	NULL
effecter	NULL
T	NULL
cells	NULL
[	NULL
12,30	NULL
]	NULL
.	NULL

Rescue	NULL
from	NULL
this	NULL
apoptosis	NULL
of	NULL
T	NULL
cells	NULL
may	NULL
be	NULL
associated	NULL
with	NULL
development	NULL
of	NULL
immunological	NULL
memory	NULL
[	NULL
31,32	NULL
]	NULL
.	NULL

It	NULL
is	NULL
generally	NULL
believed	NULL
that	NULL
maintenance	NULL
of	NULL
memory	NULL
depends	NULL
on	NULL
persistence	NULL
of	NULL
antigen	NULL
[	NULL
31	NULL
]	NULL
.	NULL

We	NULL
found	NULL
that	NULL
promotes	NULL
the	NULL
survival	NULL
of	NULL
antigen-specific	NULL
T	NULL
cells	NULL
otherwise	NULL
destined	NULL
to	NULL
die	NULL
by	NULL
apoptosis	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
antigen	NULL
without	NULL
accompanying	NULL
active	NULL
cell	NULL
proliferation	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
propose	NULL
that	NULL
cytokines	NULL
such	NULL
as	NULL
IFN-w/B	NULL
may	NULL
be	NULL
important	NULL
for	NULL
the	NULL
development	NULL
and/or	NULL
maintenance	NULL
of	NULL
memory	NULL
T	NULL
cells	NULL
,	NULL
since	NULL
characteristics	NULL
of	NULL
IFN-	NULL
«	NULL
@	NULL
/B-treated	NULL
T	NULL
cells	NULL
,	NULL
that	NULL
do	NULL
not	NULL
die	NULL
or	NULL
proliferate	NULL
actively	NULL
,	NULL
may	NULL
resemble	NULL
those	NULL
of	NULL
memory	NULL
T	NULL
cells	NULL
in	NULL
resting	NULL
status	NULL
[	NULL
32,33	NULL
]	NULL
.	NULL

In	NULL
accordance	NULL
with	NULL
our	NULL
findings	NULL
,	NULL
it	NULL
has	NULL
recently	NULL
been	NULL
reported	NULL
that	NULL
IFN-w/§	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
maintenance	NULL
of	NULL
memory	NULL
T	NULL
cells	NULL
[	NULL
33	NULL
]	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
IFN-	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
inhibit	NULL
apoptotic	NULL
cell	NULL
death	NULL
of	NULL
B-chronic	NULL
lymphocytic	NULL
leukaemia	NULL
cells	NULL
cultured	NULL
in	NULL
vitro	NULL
without	NULL
growth	NULL
factors	NULL
[	NULL
34	NULL
]	NULL
.	NULL

It	NULL
has	NULL
already	NULL
been	NULL
reported	NULL
that	NULL
addition	NULL
of	NULL
fibroblasts	NULL
to	NULL
IL-2-dependent	NULL
T	NULL
cells	NULL
results	NULL
in	NULL
prolonged	NULL
survival	NULL
of	NULL
the	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
proliferation	NULL
,	NULL
suggesting	NULL
a	NULL
salvage	NULL
pathway	NULL
whereby	NULL
activated	NULL
T	NULL
cells	NULL
reverted	NULL
to	NULL
non-proliferating	NULL
cells	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
antigen	NULL
or	NULL
mitogenic	NULL
signals	NULL
[	NULL
35	NULL
]	NULL
.	NULL

Our	NULL
finding	NULL
that	NULL
treatment	NULL
rescues	NULL
T	NULL
cells	NULL
from	NULL
growth	NULL
factor	NULL
deprivation-induced	NULL
apoptosis	NULL
without	NULL
accompanying	NULL
proliferation	NULL
at	NULL
least	NULL
partly	NULL
coincides	NULL
with	NULL
these	NULL
findings	NULL
[	NULL
35	NULL
]	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
IFN-w/B	NULL
secreted	NULL
by	NULL
fibroblasts	NULL
induce	NULL
prolonged	NULL
survival	NULL
of	NULL
once	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

Treatment	NULL
with	NULL
of	NULL
MOLT16	NULL
cells	NULL
induces	NULL
augmented	NULL
apoptosis	NULL
upon	NULL
phytohaemagglutinin	NULL
(	NULL
PHA	NULL
)	NULL
activation	NULL
[	NULL
36	NULL
]	NULL
.	NULL

MOLT16	NULL
cells	NULL
represent	NULL
prethymic	NULL
T	NULL
cells	NULL
of	NULL
T	NULL
cell	NULL
differentiation	NULL
pathway	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
our	NULL
T	NULL
cell	NULL
clones	NULL
represent	NULL
circulating	NULL
mature	NULL
CD4*	NULL
T	NULL
cells	NULL
with	NULL
antigen	NULL
specificity	NULL
.	NULL

It	NULL
has	NULL
already	NULL
been	NULL
reported	NULL
that	NULL
T-B	NULL
interaction	NULL
inhibits	NULL
spontaneous	NULL
apoptosis	NULL
of	NULL
mature	NULL
peripheral	NULL
T	NULL
cells	NULL
,	NULL
but	NULL
not	NULL
immature	NULL
double-positive	NULL
thymocytes	NULL
in	NULL
Bcl-2-deficient	NULL
mice	NULL
[	NULL
36,37	NULL
]	NULL
.	NULL

We	NULL
have	NULL
confirmed	NULL
the	NULL
anti-apoptotic	NULL
effects	NULL
of	NULL
IFN-	NULL
@	NULL
/	NULL
$	NULL
8	NULL
on	NULL
more	NULL
than	NULL
12	NULL
T	NULL
cell	NULL
clones	NULL
,	NULL
two	NULL
PHA-activated	NULL
human	NULL
T	NULL
cell	NULL
lines	NULL
,	NULL
and	NULL
two	NULL
PPD-specific	NULL
T	NULL
cell	NULL
lines	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
IFN-	NULL
«	NULL
@	NULL
/	NULL
$	NULL
,	NULL
or	NULL
the	NULL
same	NULL
cytokines	NULL
exert	NULL
different	NULL
effects	NULL
on	NULL
apoptosis	NULL
of	NULL
T	NULL
cells	NULL
,	NULL
depending	NULL
on	NULL
the	NULL
T	NULL
cell	NULL
differentiation	NULL
stages	NULL
.	NULL

Dysregulated	NULL
apoptosis	NULL
is	NULL
associated	NULL
with	NULL
lymphocyte	NULL
depletion	NULL
in	NULL
human	NULL
diseases	NULL
such	NULL
as	NULL
AIDS	NULL
,	NULL
SLE	NULL
,	NULL
and	NULL
other	NULL
immunological	NULL
disorders	NULL
[	NULL
4,13,30	NULL
]	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
the	NULL
decline	NULL
of	NULL
circulating	NULL
CD4	NULL
T	NULL
cells	NULL
is	NULL
an	NULL
important	NULL
clinical	NULL
feature	NULL
and	NULL
prognostic	NULL
factor	NULL
of	NULL
patients	NULL
with	NULL
AIDS	NULL
[	NULL
38-40	NULL
]	NULL
.	NULL

Thus	NULL
,	NULL
control	NULL
of	NULL
apoptosis	NULL
is	NULL
an	NULL
important	NULL
potential	NULL
target	NULL
for	NULL
therapeutic	NULL
intervention	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
IFN-	NULL
«	NULL
treatment	NULL
induced	NULL
a	NULL
20	NULL
%	NULL
increase	NULL
in	NULL
the	NULL
CD4*~	NULL
T	NULL
cell	NULL
percentage	NULL
in	NULL
patients	NULL
with	NULL
AIDS	NULL
[	NULL
41	NULL
]	NULL
.	NULL

We	NULL
believe	NULL
that	NULL
our	NULL
present	NULL
study	NULL
gives	NULL
a	NULL
rationale	NULL
for	NULL
clinical	NULL
use	NULL
of	NULL
IFNs	NULL
to	NULL
treat	NULL
AIDS	NULL
patients	NULL
suffering	NULL
from	NULL
circulating	NULL
CD4	NULL
*	NULL
T	NULL
cell	NULL
depletion	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
Bel-2	NULL
acts	NULL
as	NULL
an	NULL
important	NULL
regulator	NULL
in	NULL
an	NULL
apoptotic	NULL
pathway	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
IFN-	NULL
@	NULL
/6B	NULL
up-regulate	NULL
Bcl-2	NULL
expression	NULL
and	NULL
protect	NULL
B-chronic	NULL
lymphocytic	NULL
leukaemia	NULL
cells	NULL
from	NULL
apoptosis	NULL
[	NULL
42	NULL
]	NULL
.	NULL

It	NULL
has	NULL
also	NULL
been	NULL
reported	NULL
that	NULL
Bel-2	NULL
protein	NULL
and	NULL
its	NULL
mRNA	NULL
expression	NULL
are	NULL
up-regulated	NULL
by	NULL
treatment	NULL
of	NULL
T	NULL
cells	NULL
with	NULL
IL-2	NULL
and	NULL
related	NULL
cytokines	NULL
[	NULL
43	NULL
]	NULL
.	NULL

However	NULL
,	NULL
we	NULL
found	NULL
that	NULL
IL-2	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
Bel-2	NULL
protein	NULL
expression	NULL
of	NULL
T	NULL
cell	NULL
clones	NULL
in	NULL
this	NULL
study	NULL
.	NULL

One	NULL
possible	NULL
explanation	NULL
of	NULL
this	NULL
difference	NULL
is	NULL
that	NULL
we	NULL
measured	NULL
Bcl-2	NULL
expression	NULL
at	NULL
a	NULL
relatively	NULL
early	NULL
time	NULL
point	NULL
(	NULL
24	NULL
h	NULL
)	NULL
,	NULL
perhaps	NULL
before	NULL
Bel-2	NULL
had	NULL
a	NULL
chance	NULL
to	NULL
drop	NULL
.	NULL

They	NULL
measured	NULL
Bel-2	NULL
expression	NULL
at	NULL
a	NULL
relatively	NULL
late	NULL
time	NULL
point	NULL
.	NULL

Another	NULL
possibility	NULL
is	NULL
that	NULL
our	NULL
T	NULL
cell	NULL
clones	NULL
were	NULL
selected	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
growth	NULL
advantage	NULL
(	NULL
or	NULL
resistance	NULL
to	NULL
cell	NULL
death	NULL
)	NULL
in	NULL
the	NULL
in	NULL
vitro	NULL
culture	NULL
,	NULL
that	NULL
may	NULL
have	NULL
association	NULL
with	NULL
high	NULL
Bcl-2	NULL
expression	NULL
.	NULL

Thus	NULL
,	NULL
our	NULL
clones	NULL
may	NULL
not	NULL
exhibit	NULL
further	NULL
enhancement	NULL
of	NULL
Bel-2	NULL
expression	NULL
in	NULL
response	NULL
to	NULL
IL-2	NULL
.	NULL

Our	NULL
antigen-specific	NULL
T	NULL
cells	NULL
rescued	NULL
by	NULL
treatment	NULL
showed	NULL
stable	NULL
expression	NULL
of	NULL
Bel-2	NULL
protein	NULL
and	NULL
other	NULL
apoptosis-associated	NULL
proteins	NULL
,	NULL
and	NULL
they	NULL
located	NULL
in	NULL
Gy/G	NULL
phase	NULL
of	NULL
cell	NULL
cycle	NULL
.	NULL

STATs	NULL
are	NULL
central	NULL
mediators	NULL
of	NULL
cytokine-induced	NULL
transcriptional	NULL
activation	NULL
[	NULL
42	NULL
]	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
induce	NULL
,	NULL
through	NULL
activation	NULL
of	NULL
JAK	NULL
family	NULL
kinases	NULL
,	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
nuclear	NULL
translocation	NULL
of	NULL
STAT1	NULL
and	NULL
STAT2	NULL
[	NULL
24	NULL
]	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
highly	NULL
likely	NULL
that	NULL
STAT2	NULL
induced	NULL
specifically	NULL
by	NULL
treatment	NULL
transduces	NULL
anti-apoptotic	NULL
signals	NULL
to	NULL
the	NULL
nucleus	NULL
of	NULL
responding	NULL
T	NULL
cells	NULL
[	NULL
26	NULL
]	NULL
.	NULL

Indeed	NULL
,	NULL
we	NULL
have	NULL
confirmed	NULL
the	NULL
involvement	NULL
of	NULL
STAT2	NULL
in	NULL
the	NULL
anti-apoptotic	NULL
effects	NULL
of	NULL
by	NULL
Western	NULL
blotting	NULL
and	NULL
DNA	NULL
transfection	NULL
analysis	NULL
.	NULL

Thus	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
IFN-w/f	NULL
constitute	NULL
an	NULL
alternative	NULL
pathway	NULL
that	NULL
induces	NULL
transcription	NULL
of	NULL
unknown	NULL
gene	NULL
(	NULL
s	NULL
)	NULL
which	NULL
is	NULL
associated	NULL
with	NULL
inhibition	NULL
of	NULL
apoptotic	NULL
cell	NULL
death	NULL
of	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
that	NULL
anti-metabolic	NULL
effects	NULL
of	NULL
IFN-	NULL
@	NULL
w/8	NULL
are	NULL
responsible	NULL
for	NULL
the	NULL
inhibition	NULL
of	NULL
apoptosis	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
it	NULL
intriguing	NULL
to	NULL
test	NULL
whether	NULL
other	NULL
types	NULL
of	NULL
T	NULL
cell	NULL
inhibitors	NULL
such	NULL
as	NULL
retinoids	NULL
[	NULL
44	NULL
]	NULL
or	NULL
transforming	NULL
growth	NULL
factor-beta	NULL
(	NULL
TGE-§	NULL
)	NULL
[	NULL
45	NULL
]	NULL
inhibit	NULL
the	NULL
process	NULL
of	NULL
apoptotic	NULL
death	NULL
of	NULL
T	NULL
cell	NULL
clones	NULL
.	NULL

Further	NULL
efforts	NULL
are	NULL
needed	NULL
to	NULL
clarify	NULL
the	NULL
mechanisms	NULL
of	NULL
growth	NULL
factor	NULL
deprivation	NULL
apoptosis	NULL
and	NULL
the	NULL
anti-apoptotic	NULL
pathway	NULL
utilized	NULL
by	NULL
IFN-	NULL
@	NULL
/	NULL
$	NULL
.	NULL

REFERENCES	NULL
1	NULL
Ker	NULL
JFR	NULL
,	NULL
Wyllie	NULL
AH	NULL
,	NULL
Currie	NULL
AR	NULL
.	NULL

Apoptosis	NULL
:	NULL
a	NULL
basic	NULL
biological	NULL
phenomenon	NULL
with	NULL
wide-ranging	NULL
implications	NULL
in	NULL
tissue	NULL
kinetics	NULL
.	NULL

Br	NULL
J	NULL
Cancer	NULL
1972	NULL
;	NULL
26:239-57	NULL
.	NULL

2	NULL
Martin	NULL
SJ	NULL
,	NULL
Green	NULL
DR	NULL
,	NULL
Cotter	NULL
TG	NULL
.	NULL

Dicing	NULL
with	NULL
death	NULL
:	NULL
dissecting	NULL
the	NULL
components	NULL
of	NULL
the	NULL
apoptosis	NULL
machinery	NULL
.	NULL

Trends	NULL
Biochem	NULL
Sci	NULL
1994	NULL
;	NULL
19:26-30	NULL
.	NULL

3	NULL
Kroemer	NULL
G	NULL
,	NULL
Petit	NULL
P	NULL
,	NULL
Zamzami	NULL
N	NULL
,	NULL
Vayssiére	NULL
J-L	NULL
,	NULL
Mignotte	NULL
B	NULL
.	NULL

The	NULL
biochemistry	NULL
of	NULL
programmed	NULL
cell	NULL
death	NULL
.	NULL

FASEB	NULL
J	NULL
1995	NULL
;	NULL
9:1277-87	NULL
.	NULL

©	NULL
1997	NULL
Blackwell	NULL
Scbence	NULL
Ltd	NULL
,	NULL
Clinical	NULL
and	NULL
Experimental	NULL
Immunology	NULL
,	NULL
109:185-193	NULL
so	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
16	NULL
17	NULL
18	NULL
19	NULL
20	NULL
21	NULL
22	NULL
23	NULL
24	NULL
25	NULL
26	NULL
Regulation	NULL
by	NULL
cytokines	NULL
of	NULL
human	NULL
T	NULL
cell	NULL
apoptosis	NULL
Carson	NULL
DA	NULL
,	NULL
Ribeiro	NULL
JM	NULL
.	NULL

Apoptosis	NULL
and	NULL
disease	NULL
.	NULL

Lancet	NULL
1993	NULL
;	NULL
341:1251-4	NULL
.	NULL

Ellis	NULL
RE	NULL
,	NULL
Yuan	NULL
JY	NULL
,	NULL
Horvitz	NULL
HR	NULL
.	NULL

Mechanisms	NULL
and	NULL
functions	NULL
of	NULL
cell	NULL
death	NULL
.	NULL

Annu	NULL
Rev	NULL
Cell	NULL
Biol	NULL
1991	NULL
;	NULL
7:663-98	NULL
.	NULL

Gagliardini	NULL
V	NULL
,	NULL
Fernandez	NULL
P-A	NULL
,	NULL
Lee	NULL
RKK	NULL
,	NULL
Drexler	NULL
HCA	NULL
,	NULL
Rotello	NULL
RJ	NULL
,	NULL
Fishman	NULL
MC	NULL
,	NULL
Yuan	NULL
J	NULL
.	NULL

Prevention	NULL
of	NULL
vertebrate	NULL
neuronal	NULL
death	NULL
by	NULL
the	NULL
crmA	NULL
gene	NULL
.	NULL

Science	NULL
1994	NULL
;	NULL
263:826-8	NULL
.	NULL

Nicholson	NULL
DW	NULL
,	NULL
Ali	NULL
A	NULL
,	NULL
Thornberry	NULL
NA	NULL
et	NULL
al	NULL
.	NULL

Identification	NULL
and	NULL
inhibition	NULL
of	NULL
the	NULL
ICE/CED-3	NULL
protease	NULL
necessary	NULL
for	NULL
mammalian	NULL
apoptosis	NULL
.	NULL

Nature	NULL
1995	NULL
;	NULL
376:37-43	NULL
.	NULL

Kiefer	NULL
MC	NULL
,	NULL
Brauer	NULL
MJ	NULL
,	NULL
Powers	NULL
VC	NULL
,	NULL
Wu	NULL
JJ	NULL
,	NULL
Umansky	NULL
SR	NULL
,	NULL
Tomei	NULL
LD	NULL
,	NULL
Barr	NULL
PJ	NULL
.	NULL

Modulation	NULL
of	NULL
apoptosis	NULL
by	NULL
the	NULL
widely	NULL
distributed	NULL
Bcl-2	NULL
homologue	NULL
Bak	NULL
.	NULL

Nature	NULL
1995	NULL
;	NULL
374:736-9	NULL
.	NULL

Yang	NULL
E	NULL
,	NULL
Zha	NULL
J	NULL
,	NULL
Jockel	NULL
J	NULL
,	NULL
Boise	NULL
LH	NULL
,	NULL
Thompson	NULL
CB	NULL
,	NULL
Korsmeyer	NULL
SJ	NULL
.	NULL

Bad	NULL
,	NULL
a	NULL
heterodimeric	NULL
partner	NULL
for	NULL
Bcl-xL	NULL
and	NULL
Bel-2	NULL
,	NULL
displaces	NULL
Bax	NULL
and	NULL
promotes	NULL
cell	NULL
death	NULL
.	NULL

Cell	NULL
1995	NULL
;	NULL
80:285-91	NULL
.	NULL

Lassus	NULL
P	NULL
,	NULL
Ferlin	NULL
M	NULL
,	NULL
Piette	NULL
J	NULL
,	NULL
Hibner	NULL
U.	NULL
Anti-apoptotic	NULL
activity	NULL
of	NULL
low	NULL
levels	NULL
of	NULL
wild-type	NULL
p53	NULL
.	NULL

EMBO	NULL
J	NULL
1996	NULL
;	NULL
15:4566-73	NULL
.	NULL

Cory	NULL
S.	NULL
Regulation	NULL
of	NULL
lymphocyte	NULL
survival	NULL
by	NULL
the	NULL
bel-2	NULL
gene	NULL
family	NULL
.	NULL

Annu	NULL
Rev	NULL
Immunol	NULL
1995	NULL
;	NULL
13:513-43	NULL
.	NULL

Lenardo	NULL
MJ	NULL
.	NULL

Interleukin-2	NULL
programs	NULL
mouse	NULL
«	NULL
/f	NULL
T	NULL
lymphocytes	NULL
for	NULL
apoptosis	NULL
.	NULL

Nature	NULL
1991	NULL
;	NULL
353:858-61	NULL
.	NULL

Cohen	NULL
PL	NULL
,	NULL
Eisenberg	NULL
RA	NULL
.	NULL

Lpr	NULL
and	NULL
gld	NULL
:	NULL
single	NULL
gene	NULL
models	NULL
of	NULL
systemic	NULL
autoimmunity	NULL
and	NULL
lymphoproliferative	NULL
disease	NULL
.	NULL

Annu	NULL
Rev	NULL
Immunol	NULL
1991	NULL
;	NULL
9:243-69	NULL
.	NULL

Suzuki	NULL
N	NULL
,	NULL
Bianchi	NULL
E	NULL
,	NULL
Bass	NULL
H	NULL
et	NULL
al	NULL
.	NULL

Natural	NULL
killer	NULL
lines	NULL
and	NULL
clones	NULL
with	NULL
apparent	NULL
antigen-specificity	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
1990	NULL
;	NULL
172:457-62	NULL
.	NULL

Mochizuki	NULL
M	NULL
,	NULL
Suzuki	NULL
N	NULL
,	NULL
Takeno	NULL
M	NULL
et	NULL
al	NULL
.	NULL

Fine	NULL
antigen-specificity	NULL
of	NULL
human	NULL
7/8	NULL
T	NULL
cell	NULL
lines	NULL
(	NULL
Vy9	NULL
+	NULL
)	NULL
established	NULL
by	NULL
repetitive	NULL
stimulation	NULL
with	NULL
a	NULL
serotype	NULL
(	NULL
KTH-1	NULL
)	NULL
of	NULL
a	NULL
Gram-positive	NULL
bacterium	NULL
,	NULL
Sfrepfococcus	NULL
sanguis	NULL
.	NULL

Eur	NULL
J	NULL
Immunol	NULL
1994	NULL
;	NULL
24:1536-43	NULL
.	NULL

Duke	NULL
RC	NULL
,	NULL
Cohen	NULL
JJ	NULL
.	NULL

Morphological	NULL
and	NULL
biochemical	NULL
assays	NULL
of	NULL
apoptosis	NULL
.	NULL

In	NULL
:	NULL
Coligan	NULL
JE	NULL
,	NULL
Kruisbeeck	NULL
AM	NULL
,	NULL
Margulies	NULL
DH	NULL
,	NULL
Shevach	NULL
EM	NULL
,	NULL
Strober	NULL
W	NULL
,	NULL
eds	NULL
.	NULL

Current	NULL
protocols	NULL
in	NULL
immunology	NULL
.	NULL

New	NULL
York	NULL
:	NULL
Greene	NULL
Publishing/Wiley-Interscience	NULL
,	NULL
1992	NULL
;	NULL
Unit	NULL
3.17.1	NULL
.	NULL

Dive	NULL
C	NULL
,	NULL
Gregory	NULL
CD	NULL
,	NULL
Phipps	NULL
DJ	NULL
,	NULL
Evans	NULL
DL	NULL
,	NULL
Milner	NULL
AE	NULL
,	NULL
Wyllie	NULL
AH	NULL
.	NULL

Analysis	NULL
and	NULL
discrimination	NULL
of	NULL
necrosis	NULL
and	NULL
apoptosis	NULL
(	NULL
programmed	NULL
cell	NULL
death	NULL
)	NULL
by	NULL
multiparameter	NULL
flow	NULL
cytometry	NULL
.	NULL

Biochim	NULL
Biophys	NULL
Acta	NULL
1992	NULL
;	NULL
1133:275-85	NULL
.	NULL

Koizumi	NULL
H	NULL
,	NULL
Wakisaka	NULL
M	NULL
,	NULL
Nakada	NULL
K	NULL
,	NULL
Takakuwa	NULL
T	NULL
,	NULL
Fujioka	NULL
T	NULL
,	NULL
Yamate	NULL
N	NULL
,	NULL
Uchikoshi	NULL
T.	NULL
Demonstration	NULL
of	NULL
apoptosis	NULL
in	NULL
neuroblastoma	NULL
and	NULL
its	NULL
relation	NULL
to	NULL
tumour	NULL
regression	NULL
.	NULL

Virchows	NULL
Arch	NULL
1995	NULL
;	NULL
427:167-73	NULL
.	NULL

Nicoletti	NULL
I	NULL
,	NULL
Migliorati	NULL
G	NULL
,	NULL
Pagliacci	NULL
MC	NULL
,	NULL
Grignani	NULL
F	NULL
,	NULL
Riccardi	NULL
C.	NULL
A	NULL
rapid	NULL
and	NULL
simple	NULL
method	NULL
for	NULL
measuring	NULL
thymocyte	NULL
apoptosis	NULL
by	NULL
propidium	NULL
iodide	NULL
staining	NULL
and	NULL
flow	NULL
cytometry	NULL
.	NULL

J	NULL
Immunol	NULL
Methods	NULL
1991	NULL
;	NULL
139:271-9	NULL
.	NULL

Gavrieli	NULL
Y	NULL
,	NULL
Sherman	NULL
Y	NULL
,	NULL
Ben-Sasson	NULL
SA	NULL
.	NULL

Identification	NULL
of	NULL
programmed	NULL
cell	NULL
death	NULL
in	NULL
site	NULL
via	NULL
specific	NULL
labeling	NULL
of	NULL
nuclear	NULL
DNA	NULL
fragmentation	NULL
.	NULL

J	NULL
Cell	NULL
Biol	NULL
1992	NULL
;	NULL
119:493-501	NULL
.	NULL

Dignam	NULL
JD	NULL
,	NULL
Lebovitz	NULL
RM	NULL
,	NULL
Roeder	NULL
RG	NULL
.	NULL

Accurate	NULL
transcription	NULL
initiation	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
in	NULL
a	NULL
soluble	NULL
extract	NULL
from	NULL
isolated	NULL
mammalian	NULL
nuclei	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
1983	NULL
;	NULL
11:1475-89	NULL
.	NULL

Ohlsson	NULL
H	NULL
,	NULL
Edlund	NULL
T.	NULL
Sequence-specific	NULL
interactions	NULL
of	NULL
nuclear	NULL
factors	NULL
with	NULL
the	NULL
insulin	NULL
gene	NULL
enhancer	NULL
.	NULL

Cell	NULL
1986	NULL
;	NULL
45:35-44	NULL
.	NULL

Sambrook	NULL
J	NULL
,	NULL
Fritsch	NULL
EF	NULL
,	NULL
Maniatis	NULL
T.	NULL
Transfection	NULL
mediated	NULL
by	NULL
DEAE-Dextran	NULL
.	NULL

In	NULL
:	NULL
Sambrook	NULL
J	NULL
,	NULL
Fritsch	NULL
EF	NULL
,	NULL
Maniatis	NULL
T	NULL
,	NULL
eds	NULL
.	NULL

Molecular	NULL
cloning	NULL
,	NULL
2nd	NULL
edn	NULL
.	NULL

New	NULL
York	NULL
:	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
,	NULL
1989:16.41	NULL
.	NULL

Thle	NULL
JN	NULL
.	NULL

Cytokine	NULL
receptor	NULL
signaling	NULL
.	NULL

Nature	NULL
1995	NULL
;	NULL
377:591-4	NULL
.	NULL

Leung	NULL
S	NULL
,	NULL
Qureshi	NULL
SA	NULL
,	NULL
Kerr	NULL
IM	NULL
,	NULL
Darnell	NULL
JE	NULL
Jr	NULL
,	NULL
Stark	NULL
GR	NULL
.	NULL

Role	NULL
of	NULL
STAT2	NULL
in	NULL
the	NULL
alpha	NULL
interferon	NULL
signaling	NULL
pathway	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
1995	NULL
;	NULL
15:1312-7	NULL
.	NULL

Fu	NULL
X-Y	NULL
,	NULL
Schindler	NULL
C	NULL
,	NULL
Improta	NULL
T	NULL
,	NULL
Aebersold	NULL
R	NULL
,	NULL
Darnell	NULL
JE	NULL
Jr	NULL
.	NULL

The	NULL
proteins	NULL
of	NULL
ISGF-3	NULL
,	NULL
the	NULL
interferon	NULL
«	NULL
-induced	NULL
transcriptional	NULL
activator	NULL
,	NULL
27	NULL
28	NULL
29	NULL
30	NULL
31	NULL
32	NULL
33	NULL
34	NULL
35	NULL
36	NULL
37	NULL
38	NULL
39	NULL
40	NULL
41	NULL
42	NULL
43	NULL
45	NULL
46	NULL
193	NULL
define	NULL
a	NULL
gene	NULL
family	NULL
involved	NULL
in	NULL
signal	NULL
transduction	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
1992	NULL
;	NULL
89:7840-3	NULL
.	NULL

Hou	NULL
J	NULL
,	NULL
Schindler	NULL
U	NULL
,	NULL
Henzel	NULL
WJ	NULL
,	NULL
Wong	NULL
SC	NULL
,	NULL
McKnight	NULL
SL	NULL
.	NULL

Identification	NULL
and	NULL
purification	NULL
of	NULL
human	NULL
Stat	NULL
proteins	NULL
activated	NULL
in	NULL
response	NULL
to	NULL
interleukin-2	NULL
.	NULL

Immunity	NULL
1995	NULL
;	NULL
2:321-9	NULL
.	NULL

Nielsen	NULL
M	NULL
,	NULL
Svejgaard	NULL
A	NULL
,	NULL
Skov	NULL
S	NULL
,	NULL
Odum	NULL
N.	NULL
Interleukin-2	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
nuclear	NULL
translocation	NULL
of	NULL
stat3	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

Eur	NULL
J	NULL
Immunol	NULL
1994	NULL
;	NULL
24:3082-6	NULL
.	NULL

Fu	NULL
X-Y	NULL
.	NULL

A	NULL
transcription	NULL
factor	NULL
with	NULL
SH2	NULL
and	NULL
SH3	NULL
domains	NULL
is	NULL
directly	NULL
activated	NULL
by	NULL
an	NULL
interferon	NULL
«	NULL
-induced	NULL
cytoplasmic	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
(	NULL
s	NULL
)	NULL
.	NULL

Cell	NULL
1992	NULL
;	NULL
70:323-35	NULL
.	NULL

Kroemer	NULL
G.	NULL
The	NULL
pharmacology	NULL
of	NULL
T	NULL
cell	NULL
apoptosis	NULL
.	NULL

Adv	NULL
Immunol	NULL
1995	NULL
;	NULL
58:211-96	NULL
.	NULL

Sprent	NULL
J.	NULL
T	NULL
lymphocytes	NULL
and	NULL
the	NULL
thymus	NULL
.	NULL

In	NULL
:	NULL
Paul	NULL
WE	NULL
,	NULL
ed	NULL
.	NULL

Fundamental	NULL
immunology	NULL
,	NULL
3rd	NULL
edn	NULL
.	NULL

New	NULL
York	NULL
:	NULL
Raven	NULL
Press	NULL
,	NULL
1993:75-109	NULL
.	NULL

Akbar	NULL
AN	NULL
,	NULL
Salmon	NULL
M	NULL
,	NULL
Savill	NULL
J	NULL
,	NULL
Janossy	NULL
G.	NULL
A	NULL
possible	NULL
role	NULL
for	NULL
bel-2	NULL
in	NULL
regulating	NULL
T-cell	NULL
memory	NULL
-	NULL
a	NULL
balancing	NULL
act	NULL
'	NULL
between	NULL
cell	NULL
death	NULL
and	NULL
survival	NULL
.	NULL

Immunol	NULL
Today	NULL
1993	NULL
;	NULL
14:526-32	NULL
.	NULL

Tough	NULL
DF	NULL
,	NULL
Borrow	NULL
P	NULL
,	NULL
Sprent	NULL
J	NULL
.	NULL

Induction	NULL
of	NULL
bystander	NULL
T	NULL
cell	NULL
proliferation	NULL
by	NULL
viruses	NULL
and	NULL
type	NULL
I	NULL
interferon	NULL
in	NULL
vivo	NULL
.	NULL

Science	NULL
1996	NULL
;	NULL
272:1947-50	NULL
.	NULL

Panayiotidis	NULL
P	NULL
,	NULL
Ganeshaguru	NULL
K	NULL
,	NULL
Jabbar	NULL
SAB	NULL
,	NULL
Hoffbrand	NULL
AV	NULL
.	NULL

Alpha-interferon	NULL
(	NULL
-IFN	NULL
)	NULL
protects	NULL
B-chronic	NULL
lymphocytic	NULL
leukaemia	NULL
cells	NULL
from	NULL
apoptotic	NULL
cell	NULL
death	NULL
in	NULL
vitro	NULL
.	NULL

Br	NULL
J	NULL
Haematol	NULL
1994	NULL
;	NULL
86:169-73	NULL
.	NULL

Scott	NULL
S	NULL
,	NULL
Pandolfi	NULL
F	NULL
,	NULL
Kurnick	NULL
JT	NULL
.	NULL

Fibroblasts	NULL
mediate	NULL
T	NULL
cell	NULL
survival	NULL
:	NULL
a	NULL
proposed	NULL
mechanism	NULL
for	NULL
retention	NULL
of	NULL
primed	NULL
T	NULL
cells	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
1990	NULL
;	NULL
172:1873-6	NULL
.	NULL

Dao	NULL
T	NULL
,	NULL
Ariyasu	NULL
T	NULL
,	NULL
Holgn	NULL
V	NULL
,	NULL
Minowada	NULL
J	NULL
.	NULL

Natural	NULL
human	NULL
interferon-	NULL
«	NULL
augments	NULL
apoptosis	NULL
in	NULL
activated	NULL
T	NULL
cell	NULL
line	NULL
.	NULL

Cell	NULL
Immunol	NULL
1994	NULL
;	NULL
155:304-11	NULL
.	NULL

Nakayama	NULL
K-I	NULL
,	NULL
Nakayama	NULL
K	NULL
,	NULL
Dustin	NULL
LB	NULL
,	NULL
Loh	NULL
DY	NULL
.	NULL

T-B	NULL
cell	NULL
interaction	NULL
inhibits	NULL
spontaneous	NULL
apoptosis	NULL
of	NULL
mature	NULL
lymphocytes	NULL
in	NULL
Bcl-2-deficient	NULL
mice	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
1995	NULL
;	NULL
182:1101-9	NULL
.	NULL

Fauci	NULL
AS	NULL
.	NULL

The	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
:	NULL
infectivity	NULL
and	NULL
mechanisms	NULL
of	NULL
pathogenesis	NULL
.	NULL

Science	NULL
1988	NULL
;	NULL
239:617-22	NULL
.	NULL

Banda	NULL
NK	NULL
,	NULL
Bernier	NULL
J	NULL
,	NULL
Kurahara	NULL
DK	NULL
,	NULL
Kurrle	NULL
R	NULL
,	NULL
Haigwood	NULL
N	NULL
,	NULL
Sekaly	NULL
R-P	NULL
,	NULL
Finkel	NULL
TH	NULL
.	NULL

Crosslinking	NULL
CD4	NULL
by	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
gp120	NULL
primes	NULL
T	NULL
cells	NULL
for	NULL
activation-induced	NULL
apoptosis	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
1992	NULL
;	NULL
176:1099-106	NULL
.	NULL

Ho	NULL
DD	NULL
,	NULL
Neumann	NULL
AU	NULL
,	NULL
Perelson	NULL
AS	NULL
,	NULL
Chen	NULL
W	NULL
,	NULL
Leonard	NULL
JM	NULL
,	NULL
Markowitz	NULL
M.	NULL
Rapid	NULL
turnover	NULL
of	NULL
plasma	NULL
virions	NULL
and	NULL
CD4	NULL
lymphocytes	NULL
in	NULL
HIV-1	NULL
infection	NULL
.	NULL

Nature	NULL
1995	NULL
;	NULL
373:123-6	NULL
.	NULL

Lane	NULL
HC	NULL
.	NULL

Interferons	NULL
in	NULL
HIV	NULL
and	NULL
related	NULL
diseases	NULL
.	NULL

AIDS	NULL
1994	NULL
;	NULL
8	NULL
(	NULL
Suppl	NULL
.	NULL

3	NULL
)	NULL
:519-23	NULL
.	NULL

Jewell	NULL
AP	NULL
,	NULL
Worman	NULL
CP	NULL
,	NULL
Lydyard	NULL
PM	NULL
,	NULL
Yong	NULL
KL	NULL
,	NULL
Giles	NULL
FJ	NULL
,	NULL
Goldstone	NULL
AH	NULL
.	NULL

Interferon-alpha	NULL
up-regulates	NULL
bel-2	NULL
expression	NULL
and	NULL
protects	NULL
B-CLL	NULL
cells	NULL
from	NULL
apoptosis	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
.	NULL

Br	NULL
J	NULL
Haematol	NULL
1994	NULL
;	NULL
88:268-74	NULL
.	NULL

Akbar	NULL
AN	NULL
,	NULL
Borthwick	NULL
NJ	NULL
,	NULL
Wickremasinghe	NULL
RG	NULL
et	NULL
al	NULL
.	NULL

Interleukin-2	NULL
receptor	NULL
common	NULL
gamma-chain	NULL
signaling	NULL
cytokines	NULL
regulate	NULL
activated	NULL
T	NULL
cell	NULL
apoptosis	NULL
in	NULL
response	NULL
to	NULL
growth	NULL
factor	NULL
withdrawal	NULL
:	NULL
selective	NULL
induction	NULL
of	NULL
anti-apoptotic	NULL
(	NULL
bel-2	NULL
,	NULL
bel-xL	NULL
)	NULL
but	NULL
not	NULL
pro-apoptotic	NULL
(	NULL
bax	NULL
,	NULL
bel-xS	NULL
)	NULL
gene	NULL
expression	NULL
.	NULL

Eur	NULL
J	NULL
Immunol	NULL
1996	NULL
;	NULL
26:294-9	NULL
.	NULL

Beadling	NULL
C	NULL
,	NULL
Guschin	NULL
D	NULL
,	NULL
Witthuhn	NULL
BA	NULL
,	NULL
Ziemiecki	NULL
A	NULL
,	NULL
Thle	NULL
JN	NULL
,	NULL
Kerr	NULL
IM	NULL
,	NULL
Cantrell	NULL
DA	NULL
.	NULL

Activation	NULL
of	NULL
JAK	NULL
kinases	NULL
and	NULL
STAT	NULL
proteins	NULL
by	NULL
interleukin-2	NULL
and	NULL
interferon-a	NULL
,	NULL
but	NULL
not	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
,	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

EMBO	NULL
J	NULL
1994	NULL
;	NULL
13:5605-15	NULL
.	NULL

Yang	NULL
Y	NULL
,	NULL
Minucci	NULL
S	NULL
,	NULL
Ozato	NULL
K	NULL
,	NULL
Heyman	NULL
RA	NULL
,	NULL
Ashwell	NULL
JD	NULL
.	NULL

Efficient	NULL
inhibition	NULL
of	NULL
activation-induced	NULL
Fas	NULL
ligand	NULL
upregulation	NULL
and	NULL
T	NULL
cell	NULL
apoptosis	NULL
by	NULL
retinoids	NULL
requires	NULL
occupancy	NULL
of	NULL
both	NULL
retinoid	NULL
X	NULL
receptors	NULL
and	NULL
retinoic	NULL
acid	NULL
receptors	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
1995	NULL
;	NULL
270:18672-7	NULL
.	NULL

Zhang	NULL
X	NULL
,	NULL
Giangreco	NULL
L	NULL
,	NULL
Broome	NULL
HE	NULL
,	NULL
Dargan	NULL
CM	NULL
,	NULL
Swain	NULL
SL	NULL
.	NULL

Control	NULL
of	NULL
CD4	NULL
effector	NULL
fate	NULL
:	NULL
transforming	NULL
growth	NULL
factor	NULL
31	NULL
and	NULL
interleukin	NULL
2	NULL
synergize	NULL
to	NULL
prevent	NULL
apoptosis	NULL
and	NULL
promote	NULL
effector	NULL
expansion	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
1995	NULL
;	NULL
182:699-709	NULL
.	NULL

©	NULL
1997	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
,	NULL
Clinical	NULL
and	NULL
Experimental	NULL
Immunology	NULL
,	NULL
109:185-193	NULL

